Microbe 2016 Disclosures Listed by Session

Session Title Disclosures Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) K. Aagaard, None. The Science of Learning L. R. Aaronson, None. Clinical Microbiology Board Review Course A. Abbott, None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance N. Abdali, None. H.I. Zgurskaya, None. Parasitology and Anti-parasitic Agents A. Abebe, None. H. Asrat, None. G. Ayana, None. Emerging Infections in HSCT: Limited Evidence (Organized in Cooperation with the European Society of Clinical Microbiology and Infectious Diseases) A. Abudayyeh, None. T. Miller-Roll, None. W. Na'amnih, None. D. Cohen, None. Y. Carmeli, Clostridium difficile Epidemiology and Control None. A. Adler, None. Epidemiology and Control of Nosocomial MDRO A. Adler, None. R. Glick,None. Y. Carmeli, None. Decoding Contamination: Addressing Contamination in the Laboratory, the Hospital and the World E. Afshinnekoo, None. S. Tripathi, None. D. Levin, None. Q. Feng, None. X. Li, None. M. Jacob, None. P. Donover, None. M. Reichman, None. A. Clark, None. A. Agarwal, Clinical Mycology None. Primer on Transplantation J. M. Aguado, None.

The Resistance Network: Interplay between Environmental, Community and Nosocomial Superbugs (Joint ASM-FEMS Symposium) M. Aires-de-Sousa, None.

Antimicrobial Stewardship II R.L. Akins, Investigator; Merck, Theravance Biopharma. M.D. Smith, None. Emerging Infections in HSCT: Limited Evidence (Organized in Cooperation with the European Society of Clinical Microbiology and Infectious Diseases) M. Akova, None.

Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) A. Aksamit, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab K. Alby, None. Novel Strategies to Help Antibiotics to Play their Role S. Ali, None. R.K. Poole, None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery M. W. Allard, None. Prevention and Treatment of Infection in the lmmunocompromised Child & Adolescent U. D. Allen, None. Foundations to Frontiers: The Molecular Revolution S. Altschul, None. More Trouble from Ticks in 2016 G. Alvarez-Hernandez, None.

P. G. Ambrose, Consultant: Arsanis, Contrafect, Merck, Kalidex, Meiji, PTC, Roche, Spero, Theravance, Tetraphase, VenatoRx, Zavante, Institute for Clinical Pharmacodynamics, Cempra, Tetraphase, Spero, Paratek, Venato, UFL, Debiopharm, Wockhardt, Contrafect, Medicines Co., Merck, GSK, 3V Biosciences, Arsanis, Nabriva. Investigator. USCAST, Zavante Therapeutics. J. McCauley: Employee; ICPD. C.M. Rubino: Employee; ICPD. K. Shareholder Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (excluding diversitied mutual funds). S.M. Bhavnani: Employee; ICPD. (PK/PD) Shareholder (excluding diversitied mutual funds); ICPD. Novel Strategies to Help Antibiotics to Play their Role R. Amin, None.

Front-end Automation in the Clinical Microbiology Laboratory N. Anderson, None. A. McMullen, None. R. Jennemann, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence D. I. Andersson, None. Measurement and Modeling of Drugs in Tissues (Organized in Cooperation with International Society of Anti-Infective Pharmacology D. R. Andes: Consultant: Astellas, Actelion, Roche, Theravance, Zavante, (ISAP)) Scynexis, Melinta. A. Andrémont: Da Volterra, Consultant, Scientific Advisor (Review Panel or Antimicrobial Resistance Control: A One-Health Approach Advisory Committee).

Carbapenemases D. Andreotti, None. A. Felici, None. M. Negri, None. C. Napolitano, None. Surveillance for the 21st Century A. Anyamba, None.

C. A. Arias, Theravance, Bayer, Merck, Novartis, Pfizer. Consultant. Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Theravance, Merck, Actavis. Grant Investigator. Pfizer, Theravance, The Continuous and Emerging Challenges, Mechanisms and Epidemiology Medecins Company, Actavis, Bayer, Novartis. Speaker's Bureau. Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution in Clinical and Public Health Microbiology G. Armstrong, None. Antimicrobial Research Award Lecture: Quinolone and Multidrug Resistance - A Formidable Foe D. M. Aronoff, Summit Pharmaceuticals. Consultant. Maurice Hilleman Award Lecture: Towards a Universal Influenza Virus Vaccine D. M. Aronoff, Summit Pharmaceuticals. Consultant.

ICAAC Lecture: Clean Hands Save Lives: Worldwide Perspectives D. M. Aronoff, Summit Pharmaceuticals. Consultant.

J. R. Arribas, Consultant. Janssen Cilag Consultant. Abbvie Consultant. BMS Consultant. Gilead. Consultant. MSD. Consultant. Viiv, Grant Investigator. Janssen Cilag, Grant Investigator. Abbvie, Grant Investigator. BMS, Grant Treatment of HIV Infection Investigator. Gilead, Grant Investigator. MSD, Grant Investigator. Microbiology Research Funding Opportunities R. M. Atlas, None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society [ICHS]) T. Auchtung, None. Establishing and Working in a Start-up Environment A. August, None. New Frontiers in HIV Cure B. Autran, Grant from Janssen, Grant Investigator. Infectious Diseases Treatment Guidelines and Beyond: Where Do We Stand in 2016? P. Auwaerter, medical-legal expert testimony. P. Auwaerter, medical-legal Lyme Disease 2016 Update expert testimony Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance A.N.G. Dabul, None. J.S. Avaca-Crusca, None. D.V. Tyne, None. M.S. Gilmore, in Gram-positive Bacteria None. I.L.B.C. Camargo, None. Infectious Disease Quiz R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator. Challenges of Infections in Lung Transplantation R. K. Avery, Shire, Merck, Chimerix, Astellas. Investigator.

Emerging Technologies and Biomarkers for Fungal Diagnostics E. N. Babady, None. On Your Bench, Get Set, Go! Practical Updates for the Clinical Microbiologist E. N. Babady, None. Microbe 2016 Disclosures Listed by Session

A. Babosan, None. F. Lebreton, None. C. de Champs, None. G. Pier, None. D. RNA Modulation and Cellular Signals in Antimicrobial Resistance Skurnik, None. T. Guillard, None.

Microbiology Career Choices: What's Available and How to Succeed N. Baker, None. J. Balada-Llasat, Biomerieux, Scientific Advisor (Review Panel or Advisory Error Rates in Clinical Microbiology Laboratories: Where Do We stand? Committee).

Emerging Technologies and Biomarkers for Fungal Diagnostics N. Banaei, None. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care R. Banerjee, None. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication M. Banks, None. At the Intersection of Art and Microbiology M. Banks, None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes P. Banning, None. Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation) A. K. Barczak, None. Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory A. P. Barker, None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical E. D. Barnett, PaxVax, Investigator. PaxVax, Scientific Advisor (Review Panel Medicine and Hygiene (ASTMH)) or Advisory Committee). New Frontiers in HIV Cure D. Barouch, None. Forty Years after the Double Bind H. A. Barton, None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes V. S. Baselski, None. Late Breaking Clinical Microbiology Updates from Laboratory Practices and Professional Affairs Committee V. S. Baselski, None. S.A. Becka, None. J.A. Gatta, None. E.T. Zeiser, None. J.J. LiPuma: Grant Investigator; AstraZeneca, Actavis. K.M. Papp-Wallace: Grant Investigator; RNA Modulation and Cellular Signals in Antimicrobial Resistance AstraZeneca, Actavis, Merck, Wockhardt. Foundations to Frontiers: The Molecular Revolution J. Beckwith, None. K. Begins: Employee; Green Mountain Antibodies. A. Maddur, None. W. Staphylococcus aureus Infection Treatments: New Compounds, New Church: Employee; Green Mountain Antibodies. P. Panizzi: None. P. Bock: Strategies None. Engaging and Inclusive Teaching in the Microbial Sciences G. S. Begley, None. Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) R. Beigi, None. Lyme Disease 2016 Update J. T. Belisle, None. F. Bellissimo-Rodrigues: None. H. Soule: None. D. Pires: None. A. Gayet- Hand Hygiene and Environmental Issues in the Healthcare Setting Ageron: None. D. Pittet: None. Clinical Virology L.A. Beltz: None. B. Beovic, MSD, unrestricted grant to University for my research. Grant Investigator. Rempex, country principal investigator in a multicentre study. Investigator. Astellas, Astra Zeneca, Pfizer, MSD, Sandoz - member of local advisory committees, Scientific Advisor (Review Panel or Advisory Controversies in Antimicrobial Stewardship Committee). B. Beovic, MSD, unrestricted grant to University for my research. Grant Investigator. Rempex, country principal investigator in a multicentre study. Investigator. Astellas, Astra Zeneca, Pfizer, MSD, Sandoz - member of local advisory committees, Scientific Advisor (Review Panel or Advisory Antimicrobial Stewardship Success Stories Committee). A. Saje: None. O. Dyar: None. A. Sustar: None. U. Mrsic: None. C. Pulcini: Antimicrobial Stewardship I None. B. Beović:None. Protecting the Food Supply: From Humble Beginnings to Next Generation PulseNet J. Besser, None. Microbe 2016 Disclosures Listed by Session

S.S. Takalkar: Employee; Wockhardt Research Center. Shareholder (excluding diversitied mutual funds); S Wockhardt Ltd. K.V. Umarkar: Employee; Wockhardt Research Center. J.S. Satav: Employee; Wockhardt Research Center. A.P. Udaykar: Employee; Wockhardt Research Center. A.M. Kulkarni: Employee; Wockhardt Research Center. S.S. Bhagwat: Employee; Wockhardt Research Center. Shareholder (excluding diversitied mutual funds); Wockhardt Ltd.,. M.V. Patel: Employee; Wockhardt Research Center. New Beta-lactamase and Carbapenemase Inhibitors Shareholder (excluding diversitied mutual funds); Wockhardt Ltd.

S. M. Bhavnani, Institute for Clinical Pharmacodynamics, Employee. USCAST, When the Standard PK/PD Model Does not Apply Member. Cempra, Melinta, Achaogen, Research Contractor.

S.M. Bhavnani: Research Relationship; Cellceutix Corp. J.P. Hammel: Research Relationship; Cellceutix Corp. A. Forrest:Research Relationship; Cellceutix Corp.S.A. VanWart: Research Relationship; Cellceutix Corp. P. Sager: Consultant; Cellceutix Corp. K.J. Tack: Consultant; Cellceutix Corp. R.W. Scott: Consultant; Cellceutix Corp. D.M. Jorgensen: Employee; Cellceutix Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Corp. Shareholder (excluding diversitied mutual funds); Cellceutix Corp. P.G. (PK/PD) Ambrose: Research Relationship; Cellceutix Corp. Challenges of Infections in Lung Transplantation S. Bhorade, None. Effective and High Impact Scientific Writing W. Bigford, BioScience Writers. Employee.

W. R. Bishai, AVISA: Scientific Advisor (Review Panel or Advisory Committee). Aiming at Non-Conventional Approaches to TB Therapies (Supported Paratek: Scientific Advisor (Review Panel or Advisory Committee). Scanogen: Jointly by the Bill & Melinda Gates Foundation) Scientific Advisor (Review Panel or Advisory Committee). Next-Generation Antimicrobial Discovery, Development, and Susceptibility Testing A. Blazier, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence J. Blázquez, None.

E. Blumberg, Site PI for clinical trials: Actelion, Ansun, Achaogen, Chimerix, Roche, Rempex. Grant Investigator. DSMB for Pfizer, BMS, and Glaxo Smith Primer on Transplantation Kline; speaker at meeting that was sponsored by Astellas

E. Blumberg, Site PI for clinical trials: Actelion, Ansun, Achaogen, Chimerix, Roche, Rempex. Grant Investigator. DSMB for Pfizer, BMS, and Glaxo Smith Literature Review Kline; speaker at meeting that was sponsored by Astellas Infectious Diseases Treatment Guidelines and Beyond: Where Do We Stand in 2016? R. A. Bonomo, None. Literature Review R. A. Bonomo, None. Top 10 Beta-lactamase Papers for 2015 R. A. Bonomo, None. New Beta-lactamase and Carbapenemase Inhibitors R. A. Bonomo, None.

M. Nukaga: Grant Investigator; AstraZeneca, Actavis. S.T. Lefurgy: None. M.D. Barnes: None. K.M. Papp-Wallace: Grant Investigator;Actavis, AstraZeneca, Merck, Wockhardt. R.A. Bonomo: Grant Investigator; Actavis, New Beta-lactamase and Carbapenemase Inhibitors AstraZeneca, Merck, Wockhardt, GSK. Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: A Cases Based Discussion R. A. Bonomo, None. Using Poll Everywhere to Engage your ID and Micro Learners B. Boslett, None.

Front-end Automation in the Clinical Microbiology Laboratory R. Botrugno: None. S. Castriciano: None.

G. Bou, Novartis: Collaborator. Pfizer: Grant Investigator. Pfizer, MSD, Interplay between Antimicrobial Resistance and Bacterial Persistence Astellas. Scientific Advisor (Review Panel or Advisory Committee). Microbe 2016 Disclosures Listed by Session

G. Bou, Pfizer: Consultant. Pfizer, Roche: Grant Investigator. Pfizer, MSD, RNA Modulation and Cellular Signals in Antimicrobial Resistance Astellas: Scientific Advisor (Review Panel or Advisory Committee). Forty Years after the Double Bind D. Boucaud, None.

Infectious Diseases Treatment Guidelines and Beyond: Where Do We H. W. Boucher, Achtellion: Consultant. Merck: Consultant.Elsevier: Stand in 2016? Consultant. Legal Expert Witness: Consultant. 2016 Cutting Edge Prevention, Diagnosis, and Treatment of Meningitis in Africa (Organized in Cooperation with the American Society of Tropical D. R. Boulware, NIH, PI on "Adjunctive Sertraline for the Treatment Of Medicine and Hygiene (ASTMH)) Cryptococcal Meningitis (ASTRO-CM) trial, Research Relationship.

Clinical Virology B. Bowland: None. T. Van: None. M. Lustestica: None. J. Dien Bard: None. Staphylococcus aureus Infection Treatments: New Compounds, New G. Brackman: None. A. Vermote: None. K. Breyne: None. E. Meyer: None. S. Strategies Van Calenbergh:None. T. Coenye: None. The Science of Learning L. Brancaccio-Taras, None. Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory J. A. Branda, bioMerieux. Grant Investigator.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists [SIDP]) W. B. Brasso, BD Diagnostic Systems, Employee. The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in S. M. Brecher, Bacterioscan, Cempra, Scientific Advisor (Review Panel or Significant Bacterial Pathogens Advisory Committee). Merck, Speaker's Bureau. What?s New with Varicella J. Breuer, None.

Epidemiology and Control of Nosocomial MDRO N.S. Britt: None. E.M. Potter: None. N. Patel: None. M.E. Steed: None. Clostridium difficile Epidemiology and Control G. Broukhanski: None. A. Wang: None. Bacterial Communication S. Brown, None. Fresh Approaches to Antibiotic Drug Discovery: Breaking from E. D. Brown, Apilli Pharmaceuticals Board Member. PureTech Health Convention Consultant.

K. Brown: Employee; Janssen Scientific Affairs. B. Patterson: Employee; Janssen Scientific Affairs. C. Liu: Employee; Janssen Research & Development. M. Patel: Employee; Janssen Scientific Affairs. R.E. Nettles: Employee; Janssen Scientific Affairs. L. Stewart: Employee; Janssen Scientific Affairs.J. Antiretrovirals for Prevention and Treatment Szwarcberg: Employee; Gilead Sciences. Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum S. Brownell, None. Practical Considerations and Novel Applications of MALDI-TOF MS in the B. Buchan, GenMark, Consultant. Meridian, GenMark, Accelerate, BD, Quidel, Clinical Laboratory Nanosphere, Research Contractor. B. Buchan, GenMark, Consultant. Meridian, GenMark, Accelerate, BD, Quidel, Making an Impact: Utilization and Outcomes in the Microbiology Lab Nanosphere, Research Contractor.

A.E. Budding: Board Member; IS-Diagnostics. Shareholder (excluding diversitied mutual funds); IS-Diagnostics. M. van der Bijl: None. C.M.J.E. Vandenbroucke-Grauls: None. P.H.M. Savelkoul: Board Member; IS- Clostridium difficile Epidemiology and Control Diagnostics. Shareholder (excluding diversitied mutual funds); IS-Diagnostics.

C.C. Bulik: Consultant; ICPD Tech. Employee; ICPD. J.C. Bader: Consultant; ICPD Tech. Employee; ICPD. S.M. Bhavnani: Employee; ICPD. Member; ICPD Tech. Shareholder (excluding diversitied mutual funds); ICPD. D.R. George: Consultant; ICPD Tech. Employee; ICPD. C.M. Rubino: Employee; ICPD. Member; ICPD Tech. Shareholder (excluding diversitied mutual funds); ICPD. P.G. Ambrose: Employee; ICPD. Member; ICPD Tech. Shareholder (excluding diversitied mutual funds); ICPD. K.L. Sweeney: Consultant; ICPD Tech. Antimicrobial Stewardship I Employee; ICPD. Microbe 2016 Disclosures Listed by Session

J.B. Bulitta: Grant Investigator; Pfizer, Cubist, Trius, Cempra, CSL. T. Velkov: Grant Investigator; The Medicines Company. K. Rogers: None. J. Shan: None. A. Oliver: Grant Investigator; Cubist, Wockhardt. R.L. Nation: Grant Investigator; The Medicines Company. J.D. Boyce: None. B.T. Tsuji:. Grant Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Investigator; Pfizer, Cubist, Cempra, GSK. C.B. Landersdorfer:Grant (PK/PD) Investigator; Pfizer, Cubist, Trius, CSL.

Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology [ISAP]) J. B. Bulitta, Pfizer, Cubist, Cempra, Trius, CSL, Grant Investigator.

Front-end Automation in the Clinical Microbiology Laboratory E. Burd, bioMerieux Scientific Advisor (Review Panel or Advisory Committee). Next-Generation Antimicrobial Discovery, Development, and Susceptibility Testing E. Burd, bioMerieux Scientific Advisor (Review Panel or Advisory Committee). C. Burnham, Monsanto Consultant. Thermofisher Consultant. Cepheid Grant Investigator. bioMerieux Grant Investigator. Accelerate Diagnostics Grant Ethics in Laboratory Medicine Investigator. C. Burnham, Monsanto Consultant. Thermofisher Consultant. Cepheid Grant Next-Generation Antimicrobial Discovery, Development, and Investigator. bioMerieux Grant Investigator. Accelerate Diagnostics Grant Susceptibility Testing Investigator.

K. Bush, Achaogen Consultant. Naeja Consultant. Achaogen Research Contractor. Actavis Research Contractor. Tetraphase Research Contractor. Achaogen Scientific Advisor (Review Panel or Advisory Committee). Allecra Scientific Advisor (Review Panel or Advisory Committee). Entasis Scientific Advisor (Review Panel or Advisory Committee). Gladius Scientific Advisor (Review Panel or Advisory Committee). Melinta Scientific Advisor (Review Panel or Advisory Committee). Roche Scientific Advisor (Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review Panel or Advisory Committee). WarpDrive Scientific Advisor (Review Panel or Advisory Committee). Fedora Shareholder (excluding diversitied mutual funds). Next-Generation Antimicrobial Discovery, Development, and Johnson & Johnson Shareholder (excluding diversitied mutual funds). Johnson Susceptibility Testing & Johnson. S. Bush: Employee; Gilead Sciences. D. Magnuson: Employee; Gilead Sciences. M. Rawlings: Employee; Gilead Sciences. T. Hawkins: Employee; Gilead Sciences.S. McCallister: Employee; Gilead Sciences.R. Mera Antiretrovirals for Prevention and Treatment Giler:Employee; Gilead Sciences. Microbe 2016 Disclosures Listed by Session

K. Bush, Achaogen Consultant. Naeja Consultant. Achaogen Research Contractor. Actavis Research Contractor. Tetraphase Research Contractor. Achaogen Scientific Advisor (Review Panel or Advisory Committee). Allecra Scientific Advisor (Review Panel or Advisory Committee). Entasis Scientific Advisor (Review Panel or Advisory Committee). Gladius Scientific Advisor (Review Panel or Advisory Committee). Melinta Scientific Advisor (Review Panel or Advisory Committee). Roche Scientific Advisor (Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review Panel or Advisory Committee). WarpDrive Scientific Advisor (Review Panel or Advisory Committee). Fedora Shareholder (excluding diversitied mutual funds). Johnson & Johnson Shareholder (excluding diversitied mutual funds). Johnson New Beta-lactamase and Carbapenemase Inhibitors & Johnson. Prevention and Treatment of Infection in the lmmunocompromised Child & Adolescent K. M. Butler, None. J.M. Buyck: None. P. Saint Auguste: None. C. Schleberger: None. D. Bumann: New insights on Emerging Resistance Mechanisms in Gram-negatives None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance V. Cafiso: None. S. Stracquadanio: None. G. Pigola: None. A. Ferro: None. S. in Gram-positive Bacteria Stefani: None.

A. Caliendo, Hologic Research Relationship. T2 Biosystems Research Relationship. Roche Molecular Scientific Advisor (Review Panel or Advisory Committee). BioFire Technologies/bioMerieux Scientific Advisor (Review Panel or Advisory Committee). Quidel Scientific Advisor (Review Panel or Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory Committee). IBIS Biosciences Scientific Advisor (Review Panel or Advisory Committee). Nanosphere Scientific Advisor (Review Panel or Advisory Late Breaking Clinical Microbiology Updates from Laboratory Practices Committee). IncellDX Scientific Advisor (Review Panel or Advisory and Professional Affairs Committee Committee). New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era I. L. Camargo, None. New Frontiers in HIV Cure P. Cannon, Sangamo BioSciences, Inc., Research Relationship. Resistance Surveillance and Public Health R. Cantón, None.

Making an Impact: Utilization and Outcomes in the Microbiology Lab G. A. Capraro, None.

Interplay between Antimicrobial Resistance and Bacterial Persistence A. Carattoli, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives A. Carattoli, None. Carbapenemases A. Carattoli, None. Microbial Speciation and Antimicrobial Resistance Evolution in the Genomic Era A. Carattoli, None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance A. Carattoli, None. Implementation of the Best Infection Control Practices: Worldwide Progress Reports D. M. Cardo, None. P. C. Carling, Ecolab, Steris, AORN . Consultant. Patents Hand Hygiene and Environmental Issues in the Healthcare Setting licensed to ecolab. . Microbe 2016 Disclosures Listed by Session

NGS for Microbial Genomic Surveillance and More - One Technology Fits All J. Carriço, None. Surveillance for the 21st Century M. Carroll, Quidel Scientific Consultant. McGraw-Hill, Inc.

Who Paves the Way for Fungi: Genes or Doctors? (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) A. Carvalho, Institut Mérieux Research Contractor. Beyond the Bench: The Intangibles of Being a Microbiologist A. Casadevall, None. J. Cassell, I am Editor in Chief of the BMJ journal "Sexually Transmitted Let's Talk about Sex! STIs and the Challenges of Diagnosis and Treatment Infections". Parasitology and Anti-parasitic Agents M. Cassera, None.

M. Castanheira: Research Contractor; This study and abstract presentation were funded by a research grant from Achaogen, Inc. A.P. Davis: Research Contractor; This study and abstract presentation were funded by a research grant from Achaogen, Inc.T.B. Doyle: Research Contractor; This study and abstract presentation were funded by a research grant from Achaogen, Inc. R.E. Mendes: Research Contractor; This study and abstract presentation were funded by a research grant from Achaogen, Inc. R.N. Jones: Research Contractor; This study and abstract presentation were funded by a research New insights on Emerging Resistance Mechanisms in Gram-negatives grant from Achaogen, Inc.

Front-end Automation in the Clinical Microbiology Laboratory S. Castriciano: None. J. Steenbergern: None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria V. Cattoir, None.

Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Continuous and Emerging Challenges, Mechanisms and Epidemiology V. Cattoir, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? R. Cavagnolo, None.

H. F. Chambers, Genentech Grant Investigator. Medicines Company Grant Investigator. Genentech Scientific Advisor (Review Panel or Advisory Committee). Allergan Scientific Advisor (Review Panel or Advisory Infectious Diseases Treatment Guidelines and Beyond: Where Do We Committee). Theravance Scientific Advisor (Review Panel or Advisory Stand in 2016? Committee). MerckShareholder (excluding diversitied mutual funds). lmmunoreconstitution (IRIS): How to Diagnose? How to Differentiate? How to Treat? (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) C. Chang, None. Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists [SIDP]) S. Chen, None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) L. Chen, Shoreland, InConsultant.

K. Chiem: None. B.A. Fuentes: None. D.L. Lin: None. T. Tran: None. A. Novel Strategies to Help Antibiotics to Play their Role Jackson: None. M.S. Ramirez: None. M.E. Tolmasky: None. Using Poll Everywhere to Engage your ID and Micro Learners P. V. Chin-Hong, None. O. Cho: None. K. Park: None. E. Baek: None. M. Bak: None. O. Jang: None. I. Epidemiology and Control of MRSA Bae: None.

M.H. Chowdhury: None. L.K. Ryan: None. K.B. Freeman: Employee; Employee of Fox Chase Chemical Diversity Center. R.W. Scott: Employee; New Antifungals Employee of Fox Chase Chemical Diversity Center. G. Diamond: None. Cases in Clinical Microbiology D. Church, None. Innovations and Challenges in Pharmacokinetics/Pharmacodynamics J. Cies: Consultant; Atlantic Diagnostic Laboratories. W. Moore: None. A. (PK/PD) Enache: None. A. Chopra: None. Microbe 2016 Disclosures Listed by Session

J. D. Cirillo, Global BioDiagnostics Corp.. Consultant. Merck Grant Investigator. Global BioDiagnostics Corp. Scientific Advisor (Review Panel or Advisory Committee). Global BioDiagnostics Corp. Shareholder (excluding Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology diversitied mutual funds).

RNA Modulation and Cellular Signals in Antimicrobial Resistance L. Citterio: None. H. Franzyk: None. L. Gram: None. Primer on Transplantation C. Clancy, None. B. Decker: None. L. Chen: None. A. Sonel: None. M. Nguyen: None. B. Nosocomial Outbreaks Kreiswirth: None. C. Clancy: None.

Clinical Virology R. J. Lovich, None. R. Mody, None. J. Sherewood, None. E. A. Co, None.

Interactive Cases in Pediatric Infectious Diseases (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) S. E. Coffin, None. Tips for Writing Grant Applications E. Cohen, None. Lights, Camera, Science! Engaging Videos 101 C. Condayan, None. Microbiology in the World of Social Media C. Condayan, None.

Front-end Automation in the Clinical Microbiology Laboratory L. Conter: None. B. Massetti: None. R. Paroni: None. S. Castriciano: None. Difficult Viral Infections in HSCT C. Cordonnier, None.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume C. N. Cornelissen, None. Effective Interviewing Skills and Job Offer Negotiation C. N. Cornelissen, None. E. Charpentier: None. C. Garnaud: None. C. Wintenberger: None. J. Rendu: None. P. Pavese: None. T. Drouet: None. C. Augier: None. P. Malvezzi: Nosocomial Outbreaks None. A. Thiébaut: None. Implementation of the Best Infection Control Practices: Worldwide Progress Reports L. Correa, None. Antimicrobial Stewardship Success Stories S. E. Cosgrove, None. How to Use Behavioral Theories to Design an Effective Antimicrobial Stewardship Program S. E. Cosgrove, None. Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation) J. S. Cox, None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) C. M. Coyle, None.

On Your Bench, Get Set, Go! Practical Updates for the Clinical D. W. Craft, Sanofi-Pasteur Scientific Advisor (Review Panel or Advisory Microbiologist Committee). BioFire Scientific Advisor (Review Panel or Advisory Committee).

Nontuberculous Mycobacterium (NTM) Infections Associated with D. W. Craft, Sanofi-Pasteur Scientific Advisor (Review Panel or Advisory Cardiopulmonary Bypass Surgery: Investigation of an Outbreak Committee). BioFire Scientific Advisor (Review Panel or Advisory Committee). K. Crandall, Aperiomics Inc.. Board Member. Aperiomics Inc. Research Relationship. Aperiomics Inc. Shareholder (excluding diversitied mutual Clinical Applications of Next Generation Sequencing funds).

RNA Modulation and Cellular Signals in Antimicrobial Resistance J.K. Crane: None. B.E. Bunnell: None. K.L. Bair: None. M.D. Sutton: None. Next-Generation Antimicrobial Discovery, Development, and Susceptibility Testing D. W. M. Crook, None. Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution in Clinical and Public Health Microbiology A. Croxatto, None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria I. Takeuchi: None. T.D. Curtis: None. L. Gram: None. G. Knudsen: None.

New Antifungals M.T. Cushion: None. A. Ashbaugh: None. K. Lynch: None. M.J. Linke: None. R. Dagan, Pfizer, MSD, Genocea, Memed Consultant. Pfizer Grant Investigator. Pfizer Investigator. Pfizer Research Contractor. Pfizer Research Relationship. Pfizer< Scientific Advisor (Review Panel or Advisory Novel Vaccines: From Basic Research Through Clinical Development Committee). Pfizer, GSK Speaker's Bureau. Microbe 2016 Disclosures Listed by Session

R. Dagan, Pfizer, MSD, Genocea, Memed Consultant. Pfizer Grant Investigator. Pfizer Investigator. Pfizer Research Contractor. Pfizer Research Hot Topics in Vaccines (Organized in Cooperation with the Pediatric Relationship. Pfizer< Scientific Advisor (Review Panel or Advisory Infectious Diseases Society (PIDS)) Committee). Pfizer, GSK Speaker's Bureau. R. Dagan, Pfizer, MSD, Genocea, Memed Consultant. Pfizer Grant Investigator. Pfizer Investigator. Pfizer Research Contractor. Pfizer Research Relationship. Pfizer< Scientific Advisor (Review Panel or Advisory How to Write an Abstract Committee). Pfizer, GSK Speaker's Bureau. R. Dagan, Pfizer, MSD, Genocea, Memed Consultant. Pfizer Grant Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Investigator. Pfizer Investigator. Pfizer Research Contractor. Pfizer Research Gates Foundation) (Organized in Cooperation with the Pediatric Relationship. Pfizer< Scientific Advisor (Review Panel or Advisory Infectious Diseases Society (PIDS)) Committee). Pfizer, GSK Speaker's Bureau. Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: A Cases Based Discussion G. L. Daikos, ACHAOGEN Research Contractor. REMPEX Research Contractor. Staphylococcus aureus Infection Treatments: New Compounds, New Strategies A. Dalecki: None. F. Wolschendorf: None. L. Danziger-Isakov, Ansun Biopharma, Roche, Chimerix, Research Primer on Transplantation Contractor. L. Danziger-Isakov, Ansun Biopharma, Roche, Chimerix, Research Infectious Disease Quiz Contractor. L. Danziger-Isakov, Ansun Biopharma, Roche, Chimerix, Research Challenges of Infections in Lung Transplantation Contractor.

K. Davies: Research Relationship; Sanofi Pasteur. G. Davis: Research Relationship; Sanofi Pasteur. F. Barbut: Research Relationship; Sanofi Pasteur. C. Eckert: Research Relationship; Sanofi Pasteur. N. Petrosillo: Research Relationship; Sanofi Pasteur. R. Pisapia: Research Relationship; Sanofi Pasteur. E. Reigadas-Ramirez: Research Relationship; Sanofi Pasteur. E. Bouza: Research Relationship; Sanofi Pasteur. F. Berger: Research Relationship; Sanofi Pasteur. M. Herrmann: Research Relationship; Sanofi Clostridium difficile Epidemiology and Control Pasteur. M. Wilcox: Research Contractor; Sanofi Pasteur. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance M. Davlieva: None. A. Tovar-Yanez: None. K. DeBruler: None. P. Leonard: in Gram-positive Bacteria None. M. Zianni: None. C. Arias: None. S. Yousif: None.

Epidemiological Methods to Evaluate the Added Burden of MDRO M. de Kraker, Innovative Medicines Initiative Joint Undertaking, EU 7th Infection framework programme, EFPIA partners in kind contribution, Investigator.

Emerging Technologies and Biomarkers for Fungal Diagnostics C. Decristoforo, None. Infectious Disease Quiz K. Dee, None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery J. Dekker, None.

Novel Vaccines: From Basic Research Through Clinical Development B. DeLaine: None. C. Grassel: None. T. Wu: None. E.M. Barry: None.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology M. DeMarco, None. Escherichia coli : A Friend or an Enemy? E. Denamur, None. Basics of Pharmacokinetics and Pharmacodynamics (PK/PD) of Anti- infective Agents (Organized in Cooperation with International Society of Anti-Infective Pharmacology [ISAP]) H. Derendorf, None.

PK/PD Questions I Was Too Afraid to Ask (Organized in Cooperation with the International Society of Anti-Infective Pharmacology [ISAP]) H. Derendorf, None. Mycobacteriology 2016: Supporting the Care of Patients with Mycobacterial Infections in an Increasingly Molecular Laboratory Environment E. Desmond, None. D. Deveson Lucas: None. D. Powell: None. D. Bulach: None. A. Wright: RNA Modulation and Cellular Signals in Antimicrobial Resistance None. J. Li: None. M. Harper: None. J.D. Boyce: None. Engaging and Inclusive Teaching in the Microbial Sciences B. Dewsbury, None. Broadly Neutralizing Antibodies M. Diamond, None. Microbe 2016 Disclosures Listed by Session

P. Colson: None. C. Tamalet: None. C. Dhiver: None. I. Ravaux: None. A. Clinical Virology Stein: None. R. Didier: None. Future Microbiology-Predicting the Field in 2026 J. Dien Bard, BioFire, Nanosphere Research Relationship. Clinical Microbiology Board Review Course J. Dien Bard, None. Clinical Update on Hepatitis R. Dillingham, None. Zika Virus: An Emerging Threat G. Dimopoulos, None. D.L. Dinwiddie: None. K. Schwalm: None. W.N. Dehority: None. S.A. Clinical Virology Young:None. E. Dodds Ashley, Hospital Association of New York, Consultant. New York Antimicrobial Stewardship in Hospitals Council of Health System Pharmacists, Consultant.

C. Doern, ThermoFisher Scientific Advisor (Review Panel or Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory Committee). Nanosphere Scientific Advisor (Review Panel or Advisory Committee). Genmark Scientific Advisor (Review Panel or Advisory Pediatric Microbiology for Clinicians and Laboratorians Committee). BD. Scientific Advisor (Review Panel or Advisory Committee).

C. Doern, ThermoFisher Scientific Advisor (Review Panel or Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory Committee). Nanosphere Scientific Advisor (Review Panel or Advisory Committee). Genmark Scientific Advisor (Review Panel or Advisory Ethics in Laboratory Medicine Committee). BD. Scientific Advisor (Review Panel or Advisory Committee).

C. Doern, ThermoFisher Scientific Advisor (Review Panel or Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory Committee). Nanosphere Scientific Advisor (Review Panel or Advisory Committee). Genmark Scientific Advisor (Review Panel or Advisory Clinical Applications of Next Generation Sequencing Committee). BD. Scientific Advisor (Review Panel or Advisory Committee).

C. Doern, ThermoFisher Scientific Advisor (Review Panel or Advisory Committee). Cepheid Scientific Advisor (Review Panel or Advisory Committee). Nanosphere Scientific Advisor (Review Panel or Advisory Committee). Genmark Scientific Advisor (Review Panel or Advisory QuizBusters - So You Think You Know Clinical Microbiology? Committee). BD. Scientific Advisor (Review Panel or Advisory Committee).

Y. Doi, The Medicines Company Grant Investigator. Meiji Scientific Advisor (Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review Resistance Surveillance and Public Health Panel or Advisory Committee).

Y. Doi, The Medicines Company Grant Investigator. Meiji Scientific Advisor Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: (Review Panel or Advisory Committee). Tetraphase Scientific Advisor (Review A Cases Based Discussion Panel or Advisory Committee). Effective Interviewing Skills and Job Offer Negotiation B. Dolan, None. Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) M. Dominguez-Bello, None.

C. Donskey, 3M Board Member. Seres Health Board Member. EcoLab Research Relationship. GOJO Research Relationship. Merck Research Relationship. 3M Research Relationship. Synthetic Biologics Research Control of C. difficile Infection Relationship. CepheidResearch Relationship. Infectious Disease Quiz R. Doster, None.

J. A. Doudna, Caribou Biosciences Scientific Advisor (Review Panel or Advisory Committee). Intellia Therapeutics Scientific Advisor (Review Panel or Advisory Friends, Foes, and Foils: Defining Microbial Interactions featuring the Committee). Caribou Biosciences - Co-founder. Editas Medicine - Co-founder. ASM Lecturer and Distinguished Lecturers Intellia Therapeutics - Co-founder. Hot Topics in Antimicrobial Susceptibility Testing C. Dragoni: None. M. Ianosi-Irimie: None. N. Matluk: None. Microbe 2016 Disclosures Listed by Session

R. H. Drew, CustomID, Collaborator. American Society of Microbiology, Antimicrobial Stewardship in Hospitals Campbell University, Speaker's Bureau.

G. L. Drusano, Roche, Consultant. Polyphor, Consultant. Roche, Grant Measurement and Modeling of Drugs in Tissues (Organized in Investigator. Achaogen, Grant Investigator. NIAID, Grant Investigator. Zavante Cooperation with International Society of Anti-Infective Pharmacology Pharmaceuticals, Scientific Advisor (Review Panel or Advisory Committee). (ISAP)) Roche, Scientific Advisor (Review Panel or Advisory Committee).

G. L. Drusano, Roche, Consultant. Polyphor, Consultant. Roche, Grant Investigator. Achaogen, Grant Investigator. NIAID, Grant Investigator. Zavante Pharmaceuticals, Scientific Advisor (Review Panel or Advisory Committee). When the Standard PK/PD Model Does not Apply Roche, Scientific Advisor (Review Panel or Advisory Committee). M. Dudley, The Medicines Company, Employee. The Medicines Company, PK/PD Optimization against Carbapenamase Producing Bacteria Shareholder (excluding diversitied mutual funds). Antimicrobial Discovery Approaches E. M. Duffy, Melinta Therapeutics, Inc., Employee. Clostridium difficile Epidemiology and Control R. A. Duncan, None. J. Dunn, Nanosphere, Inc. Scientific Advisor (Review Panel or Advisory Pediatric Microbiology for Clinicians and Laboratorians Committee). J. Dunn, Nanosphere, Inc. Scientific Advisor (Review Panel or Advisory Cases in Clinical Microbiology Committee). G. Durand, biomerieux, Employee. M. Bes None. J. Veyrieras, bioMérieux, Employee. F. Javerliat, bioMérieux, Employee. F. Epidemiology and Control of MRSA Vandenesch, None. A. Tristan, None. G. Dusheiko, Gilead, AbbVie, BMS, Janssen, Merck, Consultant. Gilead, AbbVie, BMS, Janssen, Merck, Scientific Advisor (Review Panel or Advisory Clinical Update on Hepatitis Committee). Regulus, Shionogi, . O.J. Dyar: None. D. Nathwani: I.C. Gyssens: None. C. Stålsby Lundborg: None. Antimicrobial Stewardship II C. Pulcini: None.

B. Dylla: None. P. Kohner: None. S. Ihde: None. J. Berry: None. K. Monson Jobe: None. D.J. Hata:None. R. Thompson: None. T. Grys: None. R. Patel: Grant Investigator; nanoMR, BioFire, Check-Points, Curetis, 3M, Merck, Actavis, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, The Medicines Company. ; Dr. Patel has a patent Bordetella pertussis/parapertussis PCR with royalties paid to TIB, a patent Device/method for sonication with royalties paid to Samsung, and a patent anti-biofilm substance issu, non-financial support from bioMérieux, Bruker, Hand Hygiene and Environmental Issues in the Healthcare Setting Abbott, Nanosphere, Siemens, BD, from Curetis. New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era A. Earl, Synlogic, LLC, Consultant. Janssen Pharmaceuticals, Consultant. H.L. Cox: None. M.M. Richey: None. A.J. Mathers: None. W.M. Novicoff: J.C. Antimicrobial Stewardship II Eby: None.

M. S. Edwards, Pfizer Research Relationship. IDSA Clinical Practice Guidelines Committee, Scientific Advisor (Review Panel or Advisory Committee). Gates Foundation Advisory Committee for GBS MCS study, Literature Review Scientific Advisor (Review Panel or Advisory Committee). How to Write an Abstract M. S. Edwards, Pfizer, Research Relationship. Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) M. S. Edwards, Pfizer, Inc. Research Relationship. GBS Diseases: Global Challenges A. Efstratiou, None.

H. Einsele, Janssen, Board Member. Celgene, Board Member. Amgen, Board Member. Novartis, Board Member. Janssen, Consultant. Celgene, Consultant. Aspergillosis following Viral Infections Amgen, Consultant. Novartis, Consultant. Beyond the Bench: The Intangibles of Being a Microbiologist K. Elkins, None. Preparing Your Education and Engagement Research for Publication: Qualitative Research for Dummies S. Elliot, None. Microbe 2016 Disclosures Listed by Session

The Science of Learning S. Elliott, None. Surveillance for the 21st Century V. Emery, Qiagen UK.

O. Bernasconi: None. E. Kuenzli: None. J. Pires: None. S. Kasraian: A. New insights on Emerging Resistance Mechanisms in Gram-negatives Carattoli: None. C. Hatz: V. Perreten: None. A. Endimiani: None. New insights into Urinary Tract Infections D. Eris, None. C.W. Euler: None. N. Frank: None. V.A. Fischetti: Research Relationship; Staphylococcus aureus Infection Treatments: New Compounds, New Contrafect Corporation. Scientific Advisor (Review Panel or Advisory Strategies Committee); Contrafect Corporation. Advances in Study Design S. Evans, None. Alexander Fleming and the Beginnings of Biofilm Research D. E. Eveleigh, None.

Novel Insights into C. difficile Pathogenesis: Toxins and Beyond R. Fagan, AvidBiotics Corp. Research Relationship. Preparing Your Education and Engagement Research for Publication: Qualitative Research for Dummies B. Fahnert, None.

Non-Tuberculous Mycobacteria (Organized in Cooperation with the International Society for Chem apy for Infection and Cancer) J. O. Falkinham, None. Tips for Writing Grant Applications M. Feili-Hariri, None.

Genome-wide Association Studies and Comparative Genomics for Tracking Multi-resistant and Hypervirulent Bacterial Clones A. M. S. Figueiredo, None.

Genome-wide Association Studies and Comparative Genomics for Tracking Multi-resistant and Hypervirulent Bacterial Clones A. M. S. Figueiredo, None. T. M. File, Cempra, Consultant. Melinta; Merck; MotifBio; Nabriva; Pfizer; Infectious Diseases Treatment Guidelines and Beyond: Where Do We Tetra-phase, Scientific Advisor (Review Panel or Advisory Committee). Paratek Stand in 2016? (member DSMB). Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) A. Finn, None.

Parasitology and Anti-parasitic Agents J.E. Foderaro: None. F. Tran: None. N.J. Westwood: None. G.E. Ward: None. Clinical Applications of Next Generation Sequencing B. A. Forbes, None. Advances in Clinical Microbiology from the Horse's Mouth K. M. Frank, None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery K. M. Frank, None. The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms (CRO/CPO) K. M. Frank, None. C. M. Fraser, Becton Dickinson Co., Board Member. University of Maryland Foundations to Frontiers: The Molecular Revolution School of Medicine, Employee. ID Fellows 101: For Fellows Age 18-88 D. N. Fredericks, Metrodora, Consultant. Emerging Infections in HSCT: Limited Evidence (Organized in A. Freifeld, Merck, Investigator. Merck - member of data adjudication board/ Cooperation with the European Society of Clinical Microbiology and Astellas - member of data safety monitoring board, Scientific Advisor (Review Infectious Diseases) Panel or Advisory Committee). Emerging Infections in HSCT: Limited Evidence (Organized in A. Freifeld, Merck, Investigator. Merck - member of data adjudication board/ Cooperation with the European Society of Clinical Microbiology and Astellas - member of data safety monitoring board, Scientific Advisor (Review Infectious Diseases) Panel or Advisory Committee).

PK/PD Questions I Was Too Afraid to Ask (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP)) L. Friberg, F. Hoffmann-La Roche Ltd, Collaborator. P. Hogan: None. M. Wallace: None. D.K. Warren: None. C.A. Burnham: Epidemiology and Control of Nosocomial MDRO None. S.A. Fritz: None. Infectious Disease Quiz S. Fritz, None. Establishing and Working in a Start-up Environment S. Frye, Lasergen, Inc. Employee. Microbe 2016 Disclosures Listed by Session

N. Fursova: None. E. Astashkin: None. A. Lev: None. N. Kartsev: None. E. Leonova: None. O. Ershova: None. N. Volozhantsev: None. V. Malikov: Epidemiology and Control of Nosocomial MDRO None. E. Svetoch: None. I. Dyatlov: None. C. Fyfe: Employee; C. Fyfe. K. Taquechel: Employee; Kiara Taquechel. Y. Gao: Employee; Y. Gao. J.A. Sutcliffe: Employee; J. Sutcliffe. T.H. Grossman: RNA Modulation and Cellular Signals in Antimicrobial Resistance Employee.

F. Gabbay, Phico Therapeutics Board Member. TranScrip Partners Board Member. TranScrip & clients Consultant. Phico Therapeutics Employee. TranScrip Partners, Member. TranScrip & clients Research Contractor. Phico Therapeutics Shareholder (excluding diversitied mutual funds). TranScrip Partners Shareholder (excluding diversitied Antimicrobial Discovery Approaches mutual funds).

A. Gales, AstraZeneca, MSD Board Member. PAHO, Brazilian Health The Resistance Network: Interplay between Environmental, Community Surveillance Agency Collaborator. Achaogen ACHN-490-007 and Nosocomial Superbugs (Joint ASM-FEMS Symposium) Investigator. Treatment of HIV Infection R. T. Gandhi, Educational grants from Gilead, Roche and EBSCO Treatment of HIV Infection F. Garcia, None.

Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Continuous and Emerging Challenges, Mechanisms and Epidemiology S. L. Gardete, None. NGS for Microbial Genomic Surveillance and More - One Technology Fits All J. L. Gardy, None. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication J. L. Gardy, None. M. Gaskin: None. D. Yamamura: None. J. Korver: Front-end Automation in the Clinical Microbiology Laboratory None. Antimicrobial Stewardship in Hospitals R. Gaynes, None. Emerging Viral Infections S. Gerber, None.

A. Geretti, Gilead Grant Investigator. BMS Grant Investigator. Janssen Grant Investigator. ViiV Grant Investigator. Gilead Scientific Advisor (Review Panel or Advisory Committee). BMS Scientific Advisor (Review Panel or Advisory Committee). ViiV Scientific Advisor (Review Panel or Advisory Committee). Pfizer S cientific Advisor (Review Panel or Advisory Committee). Abbott Molecular Scientific Advisor (Review Panel or Advisory Committee). Abbott Molecular Speaker's Bureau. Gilead Speaker's Bureau. Treatment of HIV Infection ViiV Speaker's Bureau. Pfizer Speaker's Bureau. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) M. A. Ghannoum, None. New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era M. S. Gilmore, None. Antiretroviral for Prevention R. Gilson, None.

Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment (Supported jointly by Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene) A. Ginsburg, None. Emerging Infections in HSCT: Limited Evidence (Organized in Cooperation with the European Society of Clinical Microbiology and Infectious Diseases) C. Girmenia, None. R. Goering, Cepheid, Merck, Actelion NGS for Microbial Genomic Surveillance and More - One Technology Fits Research Relationship. bioMérieux All Speaker's Bureau. R. Goering, Cepheid, Merck, Actelion Research Relationship. bioMérieux Clinical Applications of Next Generation Sequencing Speaker's Bureau. Microbe 2016 Disclosures Listed by Session

How to Change the Reporting of Microbiology Results to Improve Antibiotic Prescribing (Organized in Cooperation with the Society of D. A. Goff, Allergan OpGen Scientific Advisor (Review Panel or Advisory Infectious Diseases Pharmacists (SIDP)) Committee). Merck, Astellas, Cepheid Speaker's Bureau. Microbial Speciation and Antimicrobial Resistance Evolution in the Genomic Era J. Gogarten, None. Myths in Infection Control D. Goldmann, None. S. Goldstone, Merck and Co. on Gardasil Consultant. Merck and Co. Preventing Pediatric Infection (Supported jointly by the Bill & Melinda perform Gardasil trials Investigator. Merck and Co, for Gardasil Scientific Gates Foundation) (Organized in Cooperation with the Pediatric Advisor (Review Panel or Advisory Committee). Merck and Co for Gardasil Infectious Diseases Society (PIDS)) Speaker's Bureau. J.D. Puerta-Arias: None. P.A. Pino: None. J. Arango: None. A. New Antifungals Gonzalez: None.

Technology Enhanced Learning for the Infectious Diseases and Microbiology Educator (Supported jointly by IDSA and AMSMIC) R. J. Gordon, None. Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly with the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) J. Gordon, None. A. Gramatniece: None. M. Saule: None. I. Silamikelis: None. E. Dimina: None. I. Zahare: None. D. Fridmanis: None. I. Zahare: None. J. Klovins: Nosocomial Outbreaks None. U. Dumpis: None.

J. Capsec: None. D. Brand: None. A. Chaillon: None. F. Cazein: None. S. Levu: None. A. Moreau: None. J. Pillonel: None. A. Millon: None. S. Brunet: None. D. Thierry: None. D. Smith: None. F. Lot: None. F. Barin: None. L. Clinical Virology Grammatico-Guillon: None. Models and Technologies for Studying Pathogenesis A. J. Grant, None. New insights into Urinary Tract Infections M. Grayson, None. Infectious Disease Quiz M. Grayson, None. Implementation of the Best Infection Control Practices: Worldwide Progress Reports M. Grayson, None. D.A. Green: None. L. Hitoaliaj: None. S. Campbell: None. D.R. Peaper: Clinical Virology Speaker's Bureau; Nanosphere. Clinical Virology D. Green, None. Staphylococcus aureus Infection Treatments: New Compounds, New Strategies M. Greenberg: None. D. Kuo: None. G. Yu: None. M. Shoham: None. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication S. D. Greenwood, None. Challenges of Infections in Lung Transplantation A. Gregson, None. Integration of MALDI-TOF MS in Clinical Laboratories-Two Laboratories' G. Greub, with BD Kiestra on automation and with SUEZ-ONDEO on Experiences metagenomics of tap water, Research Relationship. Hot Topics in Vaccines (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) C. G. Grijalva, Pfizer InConsultant. A. Gronowski, Church and Dwight Co Inc ., Consultant. Abbott Ethics in Laboratory Medicine Laboratories Research Relationship. Resistance Surveillance and Public Health H. Grundmann, None.

Emerging Technologies and Biomarkers for Fungal Diagnostics T. Grys, None. B. Guéry, Astellas Board Member. MSD Scientific Advisor (Review Panel or Fecal Transplantation for Clostridium difficile Infection Advisory Committee). K. Gupta, Melinta Therapeutics Consultant. UpToDate, Inc Consultant. Paratek Pharmaceutical Scientific Advisor (Review Panel or Advisory Infectious Diseases Treatment Guidelines and Beyond: Where Do We Committee). Tetraphase Pharmaceutical Scientific Advisor (Review Panel or Stand in 2016? Advisory Committee). M. Litterio: None. D. Cejas: None. G. Gutkind: None. M.A. Radice: Carbapenemases None. Microbiology in the World of Social Media D. Haeusser, None. Microbe 2016 Disclosures Listed by Session

G. Haidar: None. C.J. Clancy: None. L. Chen: None. B. Kreiswirth: Carbapenemases None. M.H. Nguyen: None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes B. L. Haller, None. J. Halperin, Expert witness in medical malpractice cases related to Lyme Lyme Disease 2016 Update disease Emerging Viral Infections S. Halstead, None. Microbial Speciation and Antimicrobial Resistance Evolution in the Genomic Era A. M. Hammerum, None. R. E. Hancock, ABT Innovations Board Member. Elanco Animal Health, Attacking the MDR Puzzle from the Direction: Non-Antibiotic Approaches Consultant. ABT Innovations, Shareholder (excluding diversitied mutual to Treating Bacterial Infections funds). Alexander Fleming and the Beginnings of Biofilm Research M. J. Hanophy, None. J. Haque: None. N. Ledeboer: None. L. Michaelis: None. M. Graham: None. P. Hari: None. T. Mackey: None. K. Acker: None. R. Long: None. J.N. Wainaina: None. S. Revolinski: None. B. Shaw: None. M. Horowitz: None. S. Munoz-Price:Consultant; Xenex and Clorox. Speaker's Bureau; Clostridium difficile Epidemiology and Control Ecolab.

Myths in Infection Control S. J. Harbarth, Novatis Consultant. Bioreieax Research Relationship. D. Harmsen, Co-founder and shareholder of Ridom GmbH (Münster, NGS for Microbial Genomic Surveillance and More - One Technology Fits Germany) a bioinformatics company All Shareholder (excluding diversitied mutual funds). Clinical Microbiology Board Review Course A. Harrington, None. Advances in Clinical Microbiology from the Horse's Mouth S. Harrington, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? A. Harrington, None.

Front-end Automation in the Clinical Microbiology Laboratory S. Harrington, None. Decoding Contamination: Addressing Contamination in the Laboratory, the Hospital and the World A. Harrington, None.

Nontuberculous Mycobacterium (NTM) Infections Associated with Cardiopulmonary Bypass Surgery: Investigation of an Outbreak B. Hasse, None. Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum G. Hatfull, None. Friends, Foes, and Foils: Defining Microbial Interactions featuring the ASM Lecturer and Distinguished Lecturers G. Hatfull, None.

R. T. Hayden, Quidel Corporation, Roche Diagnostics Corporation Scientific Emerging Technologies and Biomarkers for Fungal Diagnostics Advisor (Review Panel or Advisory Committee). The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms (CRO/CPO) M. Hayden, None. G. He: None. X. Li: None. J. Jin: None. D. Lam: None. H. Chen: None. Novel Strategies to Help Antibiotics to Play their Role E. Nou: None. Establishing and Working in a Start-up Environment M. Healy, None. Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the Pediatric C. Healy, Grant recipient Novartis Vaccines-grant ended February 2015, Infectious Diseases Society (PIDS)) Research Relationship. Guess the Resistance Mechanism (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) E. Heil, Astellas Scientific Advisor (Review Panel or Advisory Committee). J. Heinrichs, science writer. Spouse/Life Partner, Consultant. Sanofi Novel Vaccines: From Basic Research Through Clinical Development Pasteur Employee. Zika Virus: An Emerging Threat F. X. Heinz, None. Microbe 2016 Disclosures Listed by Session

A. Nguyen: None. A. Heirali: None. M. Workentine: None. R. Somayaji: None. D. Storey: None. W. Leung: Grant Investigator; Gilead Sciences. B. Quon: Grant Investigator; Gilead Sciences. H. Rabin: Grant Investigator; Gilead Sciences. M. Surette: Grant Investigator; Gilead Sciences. M. Hot Topics in Antimicrobial Susceptibility Testing Parkins: Grant Investigator; Gilead Sciences. Clinical Virology Z. H. Helal, None. J. Li, None. M. I. Khan, None.

F.L. Paganelli: None. T. van de Kamer: None. R.J.L. Willems: None. H.L. Novel Strategies to Help Antibiotics to Play their Role Leavis: None. M.J.M. Bonten: None. A.P. Hendrickx: None. Microbiology Research Funding Opportunities M. Hepburn, None. Engaging and Inclusive Teaching in the Microbial Sciences J. A. Herzog, None. The Science of Learning J. A. Herzog, None.

M.F. Pritchard: Research Relationship; Algipharma AS. A.A. Jack: Research Relationship; Algipharma AS. L.C. Powell: Research Relationship; Algipharma AS. H. Sadh: Research Relationship; Algipharma AS. E. Onsøyen: Employee; Algipharma AS. P.D. Rye: Employee; Algipharma AS. K.E. Hill: Research Relationship; Algipharma AS. D.W. New Antifungals Thomas: Research Relationship; Algipharma AS. J. Hindler, Accelerate Diagnostics, Inc. Scientific Advisor (Review Panel or AST Update: Clinical and Laboratory Impact Advisory Committee). bioMerieux Speaker's Bureau. New Frontiers in HIV Cure Y. Ho, None. Emerging Viral Infections R. Hodinka, None. Big Challenges in Pre-clinical Med Student Microbiology Education (Supported jointly by IDSA and AMSMIC) R. Hodinka, None. E. Hohmann, Seres Therapeutics Consultant. Suffinova Consultant. Arkin Holdings Consultant. Back Bay Lifesciences Consultant. Seres Therapeutics Control of C. difficile Infection Research Relationship. Microbial Speciation and Antimicrobial Resistance Evolution in the Genomic Era K. Holt, None. M. Jetter: None. M. Marchesi: None. M. Hombach: None. P.M. Keller: Front-end Automation in the Clinical Microbiology Laboratory None. Antimicrobial Research Award Lecture: Quinolone and Multidrug Resistance - A Formidable Foe D. C. Hooper, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections T. M. Hooton, None. Engaging and Inclusive Teaching in the Microbial Sciences R. Horak, None. The Science of Learning R. Horak, None.

Non-Tuberculous Mycobacteria (Organized in Cooperation with the P. Hsueh, Bayer, Astrazenica, Biomerieux, BD, MSD, Sanofi, Abbott, International Society for Chem apy for Infection and Cancer) Consultant. P. Hsueh, Bayer, Astrazenica, Biomerieux, BD, MSD, Sanofi, Abbott, Fecal Transplantation for Clostridium difficile Infection Consultant.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology T. Hu, None. Lyme Disease 2016 Update L. T. Hu, Massbiologics, Research Contractor. S. Shie: None. P. Huang: None. J. Ye: None. Y. Wu: None. T. Wu: None. T. Wu: None. S. Chuang: None. M. Cheng: None. C. Huang: Antimicrobial Stewardship II None.

M.D. Huband: Research Contractor; This study and abstract presentation were funded by a research grant from Wockhardt. D.J. Farrell: Research Contractor; This study and abstract presentation were funded by a research grant from Wockhardt. R.K. Flamm: Research Contractor; This study and abstract presentation were funded by a research grant from Wockhardt. R.N. Jones: Research Contractor; This study and abstract presentation were New Beta-lactamase and Carbapenemase Inhibitors funded by a research grant from Wockhardt. Microbe 2016 Disclosures Listed by Session

Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum L. E. Hughes, None.

G. Huhn: Consultant; Gilead, Viiv.Research Contractor; Gilead, Viiv, Janssen, BMS. Scientific Advisor (Review Panel or Advisory Committee); Gilead, Viiv. B. Rijnders: Grant Investigator; Gilead, MSD. Scientific Advisor (Review Panel or Advisory Committee); Gilead, MSD, ViiV, Pfizer, Jansen-cilag, BMS, Abbvie. M. Thompson: Investigator; BMS, Gilead, Pfizer, Merck, ViiV. P. Tebas: Consultant; Merck. Investigator; Gilead. Independent Contractor; Glaxo (Adjudication committee). P. Shalit: Consultant; Gilead Sciences, Bristol Meyers-Squibb, Merck, Janssen. Research Relationship; Gilead Sciences, Janssen, Glaxo Smithkline.Speaker's Bureau; Gilead Sciences, Janssen, Bristol Meyers-Squibb, Merck. Y. Liu: Employee; Gilead Sciences. T. Nguyen-Cleary: Employee; Gilead Sciences. M. Das: Employee; Gilead Sciences. S. Antiretrovirals for Prevention and Treatment McCallister: Employee; Gilead Sciences. How to Use Behavioral Theories to Design an Effective Antimicrobial Stewardship Program M. Hulscher, None. A. Humar, Roche, Qiagen, Astellas, Research Relationship. Chimerix, Roche, Primer on Transplantation Speaker's Bureau.

R. M. Humphries, Merck Consultant. Cepheid Consultant. Roche Consultant. Nanosphere Consultant. GenMark Grant Investigator. Curetis Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Grant Investigator. BioMerieux Grant Investigator. BD . Grant Investigator. Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) Beckman Coulter Grant Investigator.

R. M. Humphries, Merck Consultant. Cepheid Consultant. Roche Consultant. Nanosphere Consultant. GenMark Grant Investigator. Curetis Grant Investigator. BioMerieux Grant Investigator. BD . Grant Investigator. Literature Review Beckman Coulter Grant Investigator. Aiming at Non-Conventional Approaches to TB Therapies (Supported Jointly by the Bill & Melinda Gates Foundation) D. Hung, None. Engaging and Inclusive Teaching in the Microbial Sciences A. Hunter, None. W. Huskins, Genentech. Scientific Advisor (Review Panel or Advisory Antimicrobial Stewardship Success Stories Committee). Advances in Study Design A. Huttner, None. Controversies in Antimicrobial Stewardship B. Huttner, None. Antimicrobial Stewardship Success Stories B. Huttner, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections A. Huttner, None.

T. Gebremariam: None. A. Alqarihi: None. P. Uppuluri: None. N. Azie: Employee; Astellas Pharma. J. Edwards, Jr.: Consultant; Astellas Pharma. Scientific Advisor (Review Panel or Advisory Committee); Astellas Pharma. A.S. Ibrahim: Consultant; Astellas Pharma. Grant Investigator; Astellas Pharma. Scientific Advisor (Review Panel or Advisory Committee); Astellas Clinical Mycology Pharma. Parasitology and Anti-parasitic Agents T. Ijaz: None. S. Aslam: None. S. Ijaz: None.

Treating Hepatitis B and Hepatitis C in Children G. Indolfi, Alexion Board Member. Gilead, Abbvie, Research Contractor.

M. G. Ison, Biota Consultant. Biota Consultant. Cellex Consultant. Clarassance Consultant. GlaxoSmithKlein Consultant. GenMarkDx Consultant. Romark Consultant. Toyama/MediVector Consultant. NexBio Consultant. Theraclone Consultant. Anolinx Research Relationship. Chimerix Research Relationship. Gilead Research Relationship. Jansen/Johnson & Emerging Viral Challenges Johnson Research Relationship. Astellas Jansen/Vertex. Microbe 2016 Disclosures Listed by Session

Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment (Supported jointly by Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene) R. Izadnegahdar, None. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory J. Jacob, Chair-Elect, Division L, ASM. Board Member. CDC, Grant for Quality Improvement and Clinical Care Investigator. Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) S. Jang, None.

NIAID Training (T), Career (K), and Fellowship (F) Opportunities G. P. Jarosik, None. 2016 Cutting Edge Prevention, Diagnosis, and Treatment of Meningitis in Africa (Organized in Cooperation with the American Society of Tropical J. Jarvis, I hold an Investigator initiated award from Gilead, Research Medicine and Hygiene (ASTMH)) Relationship. Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory A. Jassem, None. K. C. Jelden, None. P. C. Iwen, None. J. J. Herstein, None. A. L. Le, None. P. D. Biddinger, None. C. S. Kraft, None. P. W. Smith, None. A. L. Hewlett, Global Health and Emerging Infections None. S. G. Gibbs, None. J. J. Lowe, None. The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in S. Jenkins, Cempra, Bayer, Insmed, Cormedix, Merck, Roche Scientific Advisor Significant Bacterial Pathogens (Review Panel or Advisory Committee). The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in S. Jenkins, Cempra, Bayer, Insmed, Cormedix, Merck, Roche Scientific Advisor Significant Bacterial Pathogens (Review Panel or Advisory Committee).

W. Jeong: None. G.I. Snell: None. B.J. Levvey: None. G.P. Westall: None. C.O. Morrissey: Scientific Advisor (Review Panel or Advisory Committee); Advisory board for Merck, Sharp and Dohme (MSD). Received research grants from Merck, Sharp and Dohme (MSD) and Gilead Sciences; speaker honoraria from Pfizer. S. Ivulich: None. C.F. Neoh: None. M.A. Slavin: Received research grants from Merck, Sharp and Dohme (MSD), Pfizer and Gilead Sciences. D.C.M. Kong: Scientific Advisor (Review Panel or Advisory Committee); Advisory board for Merck, Sharp and Dohme (MSD) and Pfizer. Received financial support from Pfizer, Novartis, Merck, Sharp and Dohme Clinical Mycology (MSD) and Gilead Sciences. The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in Significant Bacterial Pathogens R. C. Jerris, None. D. Jin: None. C. Huang: None. Y. Luo: None. J. Cai: None. W. Fang: Clostridium difficile Epidemiology and Control None. X. Wang: None. Y. Tang: None. J. Jiang: None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes C. Johns, None.

J. R. Johnson, Crucell/Jannsen, Consultant. Actavis, Grant Investigator. Merck, Grant Investigator. Tetraphase, Grant Investigator. Duke University Escherichia coli: A Friend or an Enemy? (ARLG), Scientific Advisor (Review Panel or Advisory Committee). Guess the Resistance Mechanism (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) J. Johnson, None. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care J. Johnson, None.

M. Jonas, Gilead Sciences, DSMB, Consultant. Zoll, Spouse/Life Partner, Employee. Gilead Sciences, Bristol Myers Squibb, Roche, Echosens Treating Hepatitis B and Hepatitis C in Children Grant Investigator. Parasitology and Anti-parasitic Agents A.J. Jones: None. M. Kaiser: None. V.M. Avery: None. On Your Bench, Get Set, Go! Practical Updates for the Clinical Microbiologist M. Jones, None. Microbe 2016 Disclosures Listed by Session

Antimicrobial Breakpoints: Time for a Single CAST? G. O. Kahlmeter, Thermofisher, Consultant. AST Update: Clinical and Laboratory Impact G. O. Kahlmeter, Thermofisher, Consultant.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing A. C. Kalil, None. Staphylococcus aureus Infection Treatments: New Compounds, New Strategies R.Y. Kao: None. P. Gao: None. 2016 Update on Yaws (Organized In Cooperation with the American Society of Tropical Medicine and Hygiene) A. Kapa, None. Endocarditis in 2016 A. W. Karchmer, None. K. Kaye, Merck, Consultant. Pfizer, Consultant. The Medicines Co., Consultant. Achaogen, Consultant. Merck, Grant Investigator. Pfizer, Grant Investigator. The Medicines Co., Grant Investigator. Pfizer, Speaker's Antimicrobial Stewardship in Hospitals Bureau.

K. Kaye, Merck Consultant. Pfizer Consultant. Achaogen Consultant. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory Accelerate Grant Investigator. Merck Grant Investigator. Pfizer Grant for Quality Improvement and Clinical Care Investigator. Pfizer Speaker's Bureau.

M.S. Keckler: None. H. Moulton-Meissner: None. M.M. Lyman: None. C.T. Grigg: None. C. Bicking Kinsey: None. K.A. Perry: None. N.C. Toney: None. B. Jensen: None. J. Miller: None. J. Perz: None. K.M. Hand Hygiene and Environmental Issues in the Healthcare Setting Perkins: None. M.J. Arduino: None. J. Noble-Wang: None. Update on the Treatment of HCV/HIV Co-infection A. Kim, None. Staphylococcus aureus Infection Treatments: New Compounds, New W. Kim: None. A.L. Conery: None. B.B. Fuchs: None. F.M. Ausubel: Strategies None. E. Mylonakis: None. Implementation of the Best Infection Control Practices: Worldwide Progress Reports H. Kim, None. D. Kirui: None. G. Weber: None. T. Burton: None. N. Millenbaugh: Novel Strategies to Help Antibiotics to Play their Role None. Early New Antimicrobial Agents R. Kishii, Kyorin Pharmaceutical Co., Ltd. Employee. Ethics in Laboratory Medicine R. Klein, None. Microbiology Research Funding Opportunities K. Klugman, None.

Genome-wide Association Studies and Comparative Genomics for Tracking Multi-resistant and Hypervirulent Bacterial Clones S. Kolokotronis, None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society D. P. Kontoyiannis, Merck Consultant. Astellas Consultant. Astellas (ICHS)) Research Relationship. Merck Research Relationship. Merck, Pfizer, Astellas

D. P. Kontoyiannis, Merck Consultant. Astellas Consultant. Astellas Clinical Mycology Research Relationship. Merck Research Relationship. Merck, Pfizer, Astellas

D. P. Kontoyiannis, Merck Consultant. Astellas Consultant. Astellas Aspergillosis following Viral Infections Research Relationship. Merck Research Relationship. Merck, Pfizer, Astellas

N. Mauder: Employee; Bruker Daltonik GmbH. B. Müller: Employee; MVZ Labor Dessau GmbH. M. Kostrzewa: Employee; Bruker Daltonik GmbH. Nosocomial Outbreaks M. Wasner: Employee; MVZ Labor Dessau GmbH.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume L. Kozlowski, None. Advances in Clinical Microbiology from the Horse's Mouth C. S. Kraft, None. Microbe 2016 Disclosures Listed by Session

More Trouble from Ticks in 2016 P. J. Krause, Immunetics, Inc., L2 Diagnostics, Research Contractor. Protecting the Food Supply: From Humble Beginnings to Next Generation PulseNet K. A. Kubota, None. Antimicrobial Stewardship I R. Louis: None. S. Kuhn: None. V. Creswell: None. E. J. Kuijper, MSD, Biomerieux, Valneva, Pfizer, Astellas. Quiagen, Cubist, Control of C. difficile Infection Novartis Spouse/Life Partner, Consultant. Lyme Disease 2016 Update B. Kullberg, patent, cellular diagnostic test, Lyme disease.

D. R. Kuritzkes, Bionor Consultant. Gilead Consultant. GlaxoSmithKline Consultant. InnaVirVax Consultant. Merck Consultant. ViiV Consultant. ViroStatics Consultant. Gilead Grant Investigator. Gilead Investigator. Viiv Investigator. Bionor Investigator. Gilead Research Relationship. Merck New Frontiers in HIV Cure Research Relationship. ViiV Research Relationship. Broadly Neutralizing Antibodies D. Kwong, None.

H. Lachmann, Novartis Consultant. SOBI Consultant. Takeda Consultant. Novartis Investigator. SOBI Investigator. Celtic Investigator. Ionis/GSK Recurrent Fever in Children: Separating the Wheat from the Chaff Scientific Advisor (Review Panel or Advisory Committee).

Novel Insights into C. difficile Pathogenesis: Toxins and Beyond D. Lacy, Merck, MedImmune, Collaborator. P. Lagacé-Wiens: None. H. Adam: None. M. Baxter: None. J. Karlowsky: None. A. Walkty: None. G.G. Zhanel: Research Relationship; Cubist, Astellas, Merck, Basilea, Pharmascience, The Medicines Company, New Beta-lactamase and Carbapenemase Inhibitors Tetraphase, Sunovion. W. Lainhart: None. L. Mingle: None. M. Dickinson: None. D. Schoonmaker-Bopp: None. D. Kohlerschmidt: None. E. Nazarian: None. Epidemiology and Control of MRSA N. Dumas: None. K. Musser: None. Advances in Clinical Microbiology from the Horse's Mouth R. Lan, None. IGRAs for Risk Stratifying Transplant Donors and Recipients C. Lange, None. GBS Diseases: Global Challenges G. Langley, None.

Who Paves the Way for Fungi: Genes or Doctors? (Organized in F. Lanternier, Basilea Board Member. Gilead, MSD, Novartis Speaker's Cooperation with the lmmunocompromised Host Society (ICHS)) Bureau.

C. Lass-Floerl, Pfizer Consultant. Gilead Consultant. Basilea Consultant. MSD Consultant. Astellas Consultant. Astellas Grant Investigator. Pfizer Grant Investigator. MSD Grant Investigator. Basilea Scientific Advisor (Review Panel or Advisory Committee). Gilead Scientific Advisor (Review Top 10 Papers in Clinical Mycology (Organized in Cooperation with the Panel or Advisory Committee). MSD Scientific Advisor (Review Panel or Immunocompromised Host Society (ICHS) & European Confederation of Advisory Committee). Astellas Scientific Advisor (Review Panel or Advisory Medical Mycology (ECMM)) Committee). Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory A. Lau, None. The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms (CRO/CPO) A. Lau, None. Late Breaking Clinical Microbiology Updates from Laboratory Practices and Professional Affairs Committee A. Lau, None.

Harmful Effects of Biocide Overuse in Humans and the Environment (Supported Jointly with the Society for Applied Microbiology (SfAM)) S. Lax, None. Research Mentor Training for Microbiologists: Part I B. Lazazzera, NSF & ARO Grant Investigator. Research Mentor Training for Microbiologists: Part II B. Lazazzera, NSF & ARO Grant Investigator. Microbe 2016 Disclosures Listed by Session

A. L. Leber, ASCP Member. AMP Member. AMLI Member. BioFire Diagnositcs Research Relationship. Hologic Research Relationship. Meridian Research Relationship. Focus Diagnositcs Research Relationship. Cephid Research Relationship. BioFire Diagnostics Future Microbiology-Predicting the Field in 2026 Scientific Advisor (Review Panel or Advisory Committee).

A. L. Leber, ASCP Member. AMP Member. AMLI Member. BioFire Diagnositcs Research Relationship. Hologic Research Relationship. Meridian Research Relationship. Focus Diagnositcs Decoding Contamination: Addressing Contamination in the Laboratory, Research Relationship. Cephid Research Relationship. BioFire Diagnostics the Hospital and the World Scientific Advisor (Review Panel or Advisory Committee). New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era F. Lebreton, None. Update on Chikungunya Epidemiology, Treatment and Vaccination (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) M. Lecuit, None. Y.P. Zhou: None. S.S.L. Tang: None. W. Lee: None. Y.Y. Cai: None. T.P. Antimicrobial Stewardship I Lim: None. M.P. Chlebicki: None. A.L. Kwa: None. Hot Topics in Antimicrobial Susceptibility Testing M.J. Lee: None. J.A. Hindler: None. R.M. Humphries: None. J. Lee: None. C. Su: None. S. Chang: None. P. Shu: None. L. Huang: Global Health and Emerging Infections None.

Getting Hired: Job Search Strategies and Crafting Your CV/Resume K. Lee, None. S.H. Lee: None. K.S. Park: None. J.H. Lee: None. A.M. Karim: None. Carbapenemases M. Park: None. J.H. Kim: None. T.Y. Kim: None.

V.H. Lee: None. F. Minhaj: None. J.K. Diep: None. E.J. Ellis-Grosse: A. Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Board Member; Zavante Therapeutics, Inc. Employee; Zavante Therapeutics, (PK/PD) Inc. C.S. Abboud: None. A. Forrest: None. G.G. Rao: None. S.S.L. Tang: None. W.H.L. Lee: None. J. Teo: None. T. Lim: None. M.P. Antimicrobial Stewardship II Chlebicki: None. A.L. Kwa: None. Predicting the Impact of Antibiotic Stewardship on AMR: Simulations & Modeling B. Lee, None.

S.T. Lefurgy: None. B. Biju: None. R. Toro: None. V.N. Malashkevich: None. S.C. Almo: None. K.M. Papp-Wallace: Grant Investigator; AstraZeneca, Merck, Wockhardt, Actavis. E. Caselli: Employee; Therabor. F. Prati: Board Member; Therabor. Employee; Therabor. R.A. Bonomo: New Beta-lactamase and Carbapenemase Inhibitors Grant Investigator; AstraZeneca, Merck, Actavis, Wockhardt, GSK. M. Leone, Basilea Scientific Advisor (Review Panel or Advisory Committee). Controversies in Antimicrobial Stewardship MSD, Speaker's Bureau.

R. Clifford: None. M. Sparks: None. U. Chukwuma: None. C. Neumann: None. P. Waterman: None. E. Milburn: None. J. Moran-Gilad: None. Hot Topics in Antimicrobial Susceptibility Testing M. Julius: None. M. Hinkle: None. E. Lesho: None.

R. Clifford: None. M. Sparks: None. E. Hosford: None. A. Ong: None. D. Richesson: None. S. Fraser: None. Y. Kwak: None. S. Miller: None. Hand Hygiene and Environmental Issues in the Healthcare Setting M. Julius: None. P. McGann: None. E. Lesho: None. Antimicrobial Stewardship I G. I. S. Levy Hara, None. Antimicrobial Stewardship II G. I. S. Levy Hara, None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing G. I. S. Levy Hara, None.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in J. S. Lewis, Accelerate Diagnostics, Allergan, Astellas, Medicines Co, Merck Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) Scientific Advisor (Review Panel or Advisory Committee). Fresh Approaches to Antibiotic Drug Discovery: Breaking from K. Lewis, Novobiotic Pharmaceuticals Board Member. Arietis Board Convention Member. Microbe 2016 Disclosures Listed by Session

Next-Generation Antimicrobial Discovery, Development, and K. Lewis, Novobiotic Pharmaceuticals Board Member. Arietis Board Susceptibility Testing Member. Clinical Update on Hepatitis S. LHomme, None.

PK/PD Optimization against Carbapenamase Producing Bacteria J. Li, Rempex Pharmaceuticals, Collaborator.

Novel Vaccines: From Basic Research Through Clinical Development J. Liao: None. D.R. Smith: None. P.I. Watnick: None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical M. D. Libman, Pfizer Scientific Advisor (Review Panel or Advisory Medicine and Hygiene (ASTMH)) Committee). Epidemiology and Control of Nosocomial MDRO J. Liese: None. A. Dinkelacker: None.

Management of Cytomegalovirus A. P. Limaye, Merck Consultant. Astellas Grant Investigator. Genentech.

Infectious Disease Quiz A. P. Limaye, Merck Consultant. Astellas Grant Investigator. Genentech.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) B. Limbago, None. The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms (CRO/CPO) B. Limbago, None. Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: A Cases Based Discussion B. Limbago, None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery W. I. Lipkin, None. Antimicrobial Stewardship Success Stories J. Lipman, None. Early New Antimicrobial Agents T. Lister, IHMA, Inc., Independent Contractor.

S. Mushtaq: None. A. Vickers: None. N. Woodford: Research Contractor; Achaogen, Accelerate, Allecra, Amplex, AstraZeneca, Becton Dickinson, Meiji, Roche, Wockhardt. D.M. Livermore: Consultant; Accelerate, Achaogen, Adenium, Alere, Allecra, Altermune, Astellas, AstraZeneca, Auspherix, Basilea, Bayer, BioVersys, Cubist, Cycle, Discuva, GSK, Nordic, Meiji, Pfizer, Roche, Shionogi, Tet.Research Contractor; Roche, Melinta, Tetraphase, Wockhardt, Meiji,. K. Shareholder (excluding diversitied mutual funds); Merck, Dechra, Pfizer, Perkin Elmer, GSK.Speaker's Bureau; AOP Orphan, New Beta-lactamase and Carbapenemase Inhibitors Astellas, AstraZeneca, Curetis, Merck, Pfizer. Microbial Speciation and Antimicrobial Resistance Evolution in the Genomic Era M. J. Llewelyn, Genentech Consultant. Pfizer Consultant. Astellas Consultant. Hot Topics in Vaccines (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) S. S. Long, None.

Recurrent Fever in Children: Separating the Wheat from the Chaff S. S. Long, None. Infectious Disease Quiz S. S. Long, None. Science in 30 Seconds: Develop an Elevator Speech K. Lontok, None. How Can I Put This?: Creating Analogies K. Lontok, None.

Once Upon a Time, in a Lab Far Away?: Telling Your Science as a Story K. Lontok, None.

Innovations and Challenges in Pharmacokinetics/Pharmacodynamics C. Lu: Employee; Roche R&D Center China Ltd. Y. Zhang: None. M. Chen: (PK/PD) None. P. Zhong: None. J. Wu: None. Y. Zhang: None. J. Zhang: None.

Nontuberculous Mycobacterium (NTM) Infections Associated with Cardiopulmonary Bypass Surgery: Investigation of an Outbreak M. Lyman, None. Early New Antimicrobial Agents Z. Ma, None. Foundations to Frontiers: The Molecular Revolution L. Ma, None. Microbe 2016 Disclosures Listed by Session

A. MacGowan, Merck, Clinigen, Achaeogen,AiCuris,Tetraphase, Grant Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Investigator. Aicuris, Micron Research Research Relationship. Trustee (PK/PD) Showering Fund. Antimicrobial Stewardship II S.H. MacVane: None. L.L. Steed: None.

P.J. Maddon: Board Member; Progenics Pharmaceuticals, Inc.. Consultant; CytoDyn Inc.. K. Shareholder (excluding diversitied mutual funds) Progenics Pharmaceuticals, Inc. and CytoDyn Inc.. M. Independent Contractor; CytoDyn Inc. K. Dhody: Employee; Amarex Clinical Research, LLC. U. Kowalczyk: Employee; Quest Clinical Research. K. Kazempour: A. Board Member; Amarex Clinical Research, LLC. Employee; Amarex Clinical Research, LLC. K. Shareholder (excluding diversitied mutual funds); Amarex Clinical Research, LLC. N. Pourhassan: Board Member; CytoDyn Inc.. Employee; CytoDyn Inc. Shareholder (excluding diversitied mutual funds); CytoDyn Inc. J. Antiretrovirals for Prevention and Treatment Lalezari: Employee; Quest Clinical Research. Hot Topics in Antimicrobial Susceptibility Testing M. Maiden: None. A. Hunt: None. C. Waters: None.

Harmful Effects of Biocide Overuse in Humans and the Environment (Supported Jointly with the Society for Applied Microbiology (SfAM)) J. Maillard, Biocide consult Ltd. Independent Contractor.

Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) A. Mailles, None. Zika Virus: An Emerging Threat M. Majumder, None.

A. Wald, Vical Incorporated Investigator. A. S. Magaret, Vical Incorporated Investigator. T. J. Warren, Vical Incorporated Investigator. N. Van Wagoner, Vical Incorporated Investigator. J. D. Kriesel, Vical Incorporated Investigator. S. K. Tyring, Vical Incorporated Investigator. K. H. Fife, Vical Incorporated. Investigator. D. J. Seiden, Vical Incorporated Investigator. L. R. Smith, Vical Incorporated Employee. M. P. Clinical Virology Mammen, Vical Incorporated Employee. N. Mamuchishvili: None. K. Zakhashvili: None. D. Echeverria: None. N. Global Health and Emerging Infections Heyer: None. P. Imnadze: None. Bioinformatic Tools for WGS-based Typing of MDR Bacteria S. Mande, None. IGRAs for Risk Stratifying Transplant Donors and Recipients O. Manuel, Lophius, Qiagen, Grant Investigator. 2016 Cutting Edge Prevention, Diagnosis, and Treatment of Meningitis in Africa (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) S. Marais, None. GBS Diseases: Global Challenges I. Margarit Y Ros, Glaxo Smith Kline Employee. 2016 Update on Yaws (Organized In Cooperation with the American Society of Tropical Medicine and Hygiene) M. Marks, None. Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for Quality Improvement and Clinical Care E. M. Marlowe, None. J. Marrazzo, Symbiomix; Curatek Research Contractor. AstraZeneca; Merck Research Relationship. Cepheid Scientific Advisor (Review Panel or Let's Talk about Sex! STIs and the Challenges of Diagnosis and Treatment Advisory Committee). Effective and High Impact Scientific Writing S. Marriott, BioScience Writers Employee. Attacking the MDR Puzzle from the Direction: Non-Antibiotic Approaches to Treating Bacterial Infections J. L. Martin, None. At the Intersection of Art and Microbiology M. O. Martin, None.

R. Martinez, BioFire Diagnostics Grant Investigator. BioFire Diagnostics Making an Impact: Utilization and Outcomes in the Microbiology Lab Scientific Advisor (Review Panel or Advisory Committee). J. Martinez-Picado, Gilead, Merck Consultant. ViiV, Merck, Gilead Grant New Frontiers in HIV Cure Investigator. Microbe 2016 Disclosures Listed by Session

F. M. Marty, Alexion Consultant. Astellas Consultant. Chimerix Consultant. Fate Therapeutics Consultant Gilead Consultant. GlaxoSmithKline Consultant. LFB Consultant. Merck Consultant. Shire Consultant. Ansun Investigator. Astellas Investigator. Chimerix Investigator. Gilead Investigator. Shire Primer on Transplantation Investigator. WHISCON Investigator. The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms (CRO/CPO) A. Mathers, None. A.C. Ong: None. P. Mc Gann: None. R. Maybank: None. E. Snesrud: None. Y.I. Kwak: None. R.J. Clifford: None. M. Hinkle: None. E. Lesho: Nosocomial Outbreaks None. A. J. McAdam, Bacterioscan Inc. Scientific Advisor (Review Panel or Advisory Pediatric Microbiology for Clinicians and Laboratorians Committee). A. J. McAdam, Bacterioscan Inc. Scientific Advisor (Review Panel or Advances in Clinical Microbiology from the Horse's Mouth Advisory Committee).

Y.P. Tabak: Employee; BD. C.A. DeRyke: Employee; Merck & Co. Inc. V. Gupta: Employee; BD. D.D. DePestel: Employee; Merck & Co. Inc. S.S. Sen: Employee; Merck & Co. Inc. X. Sun: Employee; BD. R.S. Johannes: Epidemiology and Control of Nosocomial MDRO Employee; BD. E. McCann: Employee; Merck & Co. Inc.

Pneumonia Etiology of Infants in Resource Limited Settings: 2016 Update on Diagnostics, Prevention and Treatment (Supported jointly by Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene) E. D. Mccollum, None. J. E. McElhaney, Site Investigator GSK zoster vaccine trial Grant Investigator. GSK Publication Steering Committee and Advisory Panel Scientific Advisor What?s New with Varicella (Review Panel or Advisory Committee). Microbiology Research Funding Opportunities J. J. McGowan, None. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication M. Mckenna, None.

E.A. McMillan: None. S.K. Gupta: None. L. Williams: None. T. Jove: New insights on Emerging Resistance Mechanisms in Gram-negatives None. C.R. Jackson: None. M. McClelland: None. J.G. Frye: None.

Harmful Effects of Biocide Overuse in Humans and the Environment (Supported Jointly with the Society for Applied Microbiology (SfAM)) P. McNamara, None. How to Change the Reporting of Microbiology Results to Improve C. McNulty, author of antibiotic guidance in primary care Consultant. Antibiotic Prescribing (Organized in Cooperation with the Society of NICE advisory committee, Scientific Advisor (Review Panel or Advisory Infectious Diseases Pharmacists (SIDP)) Committee). More Trouble from Ticks in 2016 P. Mead, None. New insights into Urinary Tract Infections J. Meddings, None. J. Meletiadis: Grant Investigator; Astellas, Gilead, MSD, Pfizer. E. Taconelli: None. G. De Angelis: None. G. Restuccia: None. L. Preotescu: None. M. Popoiu: None. B. Carevic: None. T. Tosic: None. Y. Carmeli: None. A. Lernar: None. A. Adler: None. S. Percia: None. H. Goosens: Innovations and Challenges in Pharmacokinetics/Pharmacodynamics None. S. Malhotra-Kumar: None. C. Lammens: None. J. Mouton: (PK/PD) None. NGS for Microbial Genomic Surveillance and More - One Technology Fits All A. Mellmann, None. K. Mendoza: None. R.B. Thomson: None. D. Schora: None. L.M. Epidemiology and Control of MRSA Sabatini: None. L.R. Peterson: None. Parasitology and Anti-parasitic Agents H. Mengist: None.

D. K. Mercer, NovaBiotics Ltd Employee. D. J. Fraser-Pitt, NovaBiotics Ltd Employee. J. Robertson, NovaBiotics Ltd Employee. D. A. O'Neil, NovaBiotics Ltd Board Member. Novel Strategies to Help Antibiotics to Play their Role NovaBiotics Ltd Shareholder (excluding diversitied mutual funds). Microbe 2016 Disclosures Listed by Session

Engaging and Inclusive Teaching in the Microbial Sciences S. Merkel, None. Foundations to Frontiers: The Molecular Revolution J. Messing, None. At the Intersection of Art and Microbiology M. Middleton, None.

L. Miesel: Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara Therapeutics, Inc. K.Y. Lin: Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara Therapeutics, Inc. J.C. Chien: Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara Therapeutics, Inc. M.L. Hsieh: Employee; Eurofins Panlabs, Ltd..Research Contractor; Cidara Therapeutics, Inc. V. Ong: Employee; Cidara Therapeutics, Inc. K. New Antifungals Bartizal: Employee; Cidara Therapeutics, Inc.

A. Piazza: None. I. Bitar: None. M. Caltagirone: None. E. Nucleo: None. M. Spalla: None. F. Novazzi: None. E. Oliva: None. P. Pedroni: None. Carbapenemases R. Migliavacca: None. L. Pagani: None. L.A. Mike: None. S.N. Smith: None. C. Sumner: None. H.L.T. Mobley: Novel Vaccines: From Basic Research Through Clinical Development None.

M. Miller, Meridian Biosciences Consultant. Hologic Investigator. Luminex Protecting the Food Supply: From Humble Beginnings to Next Generation Corp., Investigator. Cepheid Investigator. Cepheid Scientific Advisor PulseNet (Review Panel or Advisory Committee).

M. Miller, Meridian Biosciences Consultant. Hologic Investigator. Luminex Late Breaking Clinical Microbiology Updates from Laboratory Practices Corp., Investigator. Cepheid Investigator. Cepheid Scientific Advisor and Professional Affairs Committee (Review Panel or Advisory Committee). Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the Pediatric K. H. Mills, Consultant to DYNAVAX. Novartis/ GSK vaccines. Research Infectious Diseases Society (PIDS)) Contractor. M. Modi: None. K. Madhavani: None. N. Patel: None. S. Nanda: None. Global Health and Emerging Infections T. Javadekar: None. S.B. Mohamed-Yussof: None. A.L.V. Melok: None. T. Chu: None. L.H. Novel Strategies to Help Antibiotics to Play their Role Lee: None. M.F. Mojica: None. K.M. Papp-Wallace: Grant Investigator; AstraZeneca, Actavis, Merck, Wockhardt. M.R. Jacobs: Grant Investigator; Wockhardt, AstraZeneca, Actavis. J.J. LiPuma: Grant Investigator; AstraZeneca, Actavis. R.A. Bonomo: Grant Investigator; AstraZeneca, Actavis, Merck, Wockhardt, New Beta-lactamase and Carbapenemase Inhibitors GSK.

J. Molina, Gilead Sciences, MSD, ViiV, Bristol Myzers Squibb. Board Literature Review Member. Gilead Grant Investigator. Gilead Speaker's Bureau. Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) D. Money, None. Biosafety and Biosecurity Lessons to Be Learned S. Monroe, None. Global Health and Emerging Infections S. Moon, None.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes A. M. Moore, None.

Fecal Transplantation for Clostridium difficile Infection T. A. Moore, None. Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly with the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical S. Moore, Lupin Pharmaceuticals, Consultant. Glycosyn Health Initiatives, Medicine and Hygiene (ASTMH)) Investigator.

Nontuberculous Mycobacterium (NTM) Infections Associated with Cardiopulmonary Bypass Surgery: Investigation of an Outbreak H. Moulton-Meissner, None. Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the Dose Wrong? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) B. Mueller, Merck, Theravance Grant Investigator. Microbe 2016 Disclosures Listed by Session

Parasitology and Anti-parasitic Agents I. Mugerwa: None. Innovations and Challenges in Pharmacokinetics/Pharmacodynamics (PK/PD) A. Muller, None. Management of Cytomegalovirus N. Müller, None. The Calm before the Storm: A Practical Guide for Surveillance of Carbapenem-resistant and Carbapenemase-producing Organisms S. Munoz-Price, Xenex Scientific Advisor (Review Panel or Advisory (CRO/CPO) Committee). Clorox, Ecolab Speaker's Bureau. Clinical Applications of Next Generation Sequencing J. Musser, None. Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum T. R. Muth, None. A.W. Mwongula: None. L.A. Mwamburi: None. M. Mwau: None. D.N. Global Health and Emerging Infections Siamba: None. F.W. Wanyama: None. On Your Bench, Get Set, Go! Practical Updates for the Clinical Microbiologist D. Myers, None. N. Nachimuthu: None. A. Ballard: None. F. Reid: None. H. Nguyen: None. A. Sirajuddin: None. J. Butler: None. J. Katz: None. L. Ostrosky: Consultant; Astellas, Merck, Scynxis, Cidara. Grant Investigator; Merck, Astellas, Pfizer, Scynexis, T2 Biosystems, Meiji, Immunetics.Speaker's Clostridium difficile Epidemiology and Control Bureau; Merck, Pfizer.

S. Naggie, HaborPath Board Member. BMS, Gilead Science Grant Investigator. IDSA Merck Member. Abbvie, BMS, Gilead Science, Janssen Pharmaceuticals, Merck, Tacere, Vertex Pharmaceuticals Research Relationship. Eviral Hep, IAS-USA, Mentor Meetings, Platform Q Health Inc., ID Fellows 101: For Fellows Age 18-88 Practice Point Communications.

Hand Hygiene and Environmental Issues in the Healthcare Setting I. Nakamura: None. T. Matsumoto: None.

Genome-wide Association Studies and Comparative Genomics for Tracking Multi-resistant and Hypervirulent Bacterial Clones A. Narechania, None. Basics of Pharmacokinetics and Pharmacodynamics (PK/PD) of Anti- infective Agents (Organized in Cooperation with International Society of Anti-Infective Pharmacology (ISAP)) R. L. Nation, None.

Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP)) R. L. Nation, None.

Front-end Automation in the Clinical Microbiology Laboratory L. Navarria: None. A. Giambra: None. S. Castriciano: None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) M. Netea, None.

Interactive Cases in Pediatric Infectious Diseases (Organized in J. Newland, RPSdiagnostics Consultant. Pfizer Cooperation with the Pediatric Infectious Diseases Society (PIDS)) Grant Investigator. Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum J. Newman, None. M. Nguyen: None. R. Rivosecchi: None. R. Shields: None. B. Falcione: None. C. Ensor: None. V. Venkataramanan: None. A. Humar: None. Clinical Mycology C. Clancy: None.

K.A. Nichol: None. H.J. Adam: None. G.R. Golding: None. M. McCracken: None. M.R. Baxter: None. J.A. Karlowsky: None. D.J. Hoban: Research Relationship; Astellas, Basilea, Merck, Abbott, Pharmascience, Sunovion, Tetraphase, The Medicines Company, Cubist. G.G. Zhanel: Research Relationship; Astellas, Basilea, Merck, Epidemiology and Control of MRSA Pharmascience, Sunovion, Tetraphase, The Medicines Company, Cubist. The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in D. P. Nicolau, AstraZeneca, Merck, Pfizer, Roche, Tetraphase Consultant. Significant Bacterial Pathogens Merck, Pfizer, Roche, Shionogi, Tetraphase Grant Investigator. Microbe 2016 Disclosures Listed by Session

C.A. Sutherland: None. J.E. Verastegui: None. D.P. Nicolau: Speaker's Hot Topics in Antimicrobial Susceptibility Testing Bureau; Bayer. When the Standard PK/PD Model Does not Apply E. Nielsen, F. Hoffmann-La Roche Ltd Research Relationship.

Non-Tuberculous Mycobacteria (Organized in Cooperation with the International Society for Chem apy for Infection and Cancer) Y. Nishiuchi, None. P. Nordmann, Antabio Scientific Advisor (Review Panel or Advisory Committee). Allecra Scientific Advisor (Review Panel or Advisory Escherichia coli : A Friend or an Enemy? Committee). P. Nordmann, Antabio Scientific Advisor (Review Panel or Advisory Committee). Allecra Scientific Advisor (Review Panel or Advisory From Phenotype to Molecular Detection: The Case of Carbapenemases Committee). Hot Topics in Antimicrobial Susceptibility Testing N. noureen: None. S. Nuralitha: None. J.E. Siregar: None. D. Syafruddin: None. S. Marzuki: Parasitology and Anti-parasitic Agents None. A.I.M. Hoepelman: None. J. Nuttall, Glaxo Smith Kline Southern Africa Advisory Board: Understanding the most appropriate pediatric dosing formulations for HIV positive pediatric Interactive Cases in Pediatric Infectious Diseases (Organized in patients in Africa Scientific Advisor (Review Cooperation with the Pediatric Infectious Diseases Society (PIDS)) Panel or Advisory Committee). Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria A.S. Nuxoll: None. K. Lewis: None. Emerging Viral Infections S. Oberste, None. Parasitology and Anti-parasitic Agents A. R. Odom, None. Broadly Neutralizing Antibodies E. Ollmann Saphire, None. Forty Years after the Double Bind M. Ong, None. D. Ono: None. T. Yamaguchi: None. M. Hamada: None. Y. Ishii: None. Novel Strategies to Help Antibiotics to Play their Role K. Tateda: None. I.O.M. Op den Buijs: None. R.T.J.M. Roymans: None. J.T.W. Nijs: None. L. van Dommelen: None. I.T.M.A. Overdevest: None. J.H.B. van de Antimicrobial Stewardship II Bovenkamp: None. Lights, Camera, Science! Engaging Videos 101 R. Ortega, None.

L. Ostrosky-Zeichner, MSG-ERC Board Member. Astellas Consultant. Cidara Consultant. MSG-ERC Consultant. Astellas Grant Investigator. T2 Biosystems Grant Investigator. Scynexis Grant Investigator. Immunetics Grant Investigator. Pfizer Grant Investigator. Merck Grant Investigator. Meiji Grant Investigator. Janssen Grant Investigator. Merck Scientific Advisor (Review Panel or Advisory Committee). T2 Biosystems Scientific Advisor (Review Panel or Advisory Committee). Cidara Scientific Advisor (Review Panel or Advisory Committee). Xenex Scientific Top 10 Papers in Clinical Mycology (Organized in Cooperation with the Advisor (Review Panel or Advisory Committee). Scynexis Scientific Advisor Immunocompromised Host Society (ICHS) & European Confederation of (Review Panel or Advisory Committee). Merck Speaker's Bureau. Pfizer Medical Mycology (ECMM)) Speaker's Bureau. Future Microbiology-Predicting the Field in 2026 K. Ota Sullivan, None. Pediatric Microbiology for Clinicians and Laboratorians K. Ota Sullivan, None. S. Otani: None. H. Takoi: None. K. Fujita: None. M. Gorai: None. R. Okuda: None. Y. Mano: None. K. Matsuda: None. Y. Saito: None. A. Epidemiology and Control of Nosocomial MDRO Gemma: None. N. Furuya: None. Foundations to Frontiers: The Molecular Revolution N. R. Pace, None. More Trouble from Ticks in 2016 C. D. Paddock, None. M. Page, Basilea Pharmaceutica International Ltd Shareholder (excluding Antimicrobial Discovery Approaches diversitied mutual funds). Aiming at Non-Conventional Approaches to TB Therapies (Supported M. Page, Basilea Pharmaceutica International Ltd Shareholder (excluding Jointly by the Bill & Melinda Gates Foundation) diversitied mutual funds). N. Palavutitotai: None. A. Jitmuang: None. S. Tongsai: None. P. Kiratisin: Epidemiology and Control of Nosocomial MDRO None. N. Augkasekwinai: None. Microbe 2016 Disclosures Listed by Session

P. Palese, GSK is providing research funds for developing a universal Maurice Hilleman Award Lecture: Towards a Universal Influenza Virus influenza virus vaccine, Research Contractor. Mount Sinai has submitted Vaccine patents in the area of a universal influenza virus vaccine New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era K. Palmer, Cubist Pharmaceuticals Grant Investigator. Top 10 Beta-lactamase Papers for 2015 T. G. Palzkill, Synthetic Biologics Consultant.

D. Pantazatos: None. E. Mavridou: None. S. Thirumuruganandham: New insights on Emerging Resistance Mechanisms in Gram-negatives None. M. Tirion: None. T.J. Walsh: None.

C.R. Bethel: None. K.M. Papp-Wallace: Grant Investigator; Wockhardt, Merck, AstraZeneca, Actavis. M.D. Barnes: None. R.A. Bonomo: Grant New Beta-lactamase and Carbapenemase Inhibitors Investigator; Wockhardt, Merck, AstraZeneca, Actavis, GSK. At the Intersection of Art and Microbiology S. Park, None. Case Management of Tropical Infectious Diseases and Travel Medicine (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) P. Parola, None. T. Parr, Spero Therapeutics Employee. Fedora Pharmaceuticals Early New Antimicrobial Agents Shareholder (excluding diversitied mutual funds). Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention T. Parr, Spero Therapeutics Consultant. Attacking the MDR Puzzle from the Direction: Non-Antibiotic Approaches to Treating Bacterial Infections T. Parr, Spero Therapeutics Employee.

Non-Tuberculous Mycobacteria (Organized in Cooperation with the International Society for Chem apy for Infection and Cancer) N. Parrish, None. N. Pettit: None. M. Miceli: None. C. Rivera: None. A. Perissinotti: None. M. Hsu: None. P. Narayanan: None. J. Pisano: Scientific Advisor (Review Panel or Advisory Committee); Astellas. S. Seo: None. A. Clinical Mycology Paskovaty: None. M.E. Patch: None. K. Napholz: None. F. Cioffi: None. M. Saunders: Antimicrobial Stewardship II None. S. Estrada: Consultant; T2 Biosystems.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) J. B. Patel, None. P. Patel: None. R. Thomson: None. L. Peterson: None. K. Mangold: Hot Topics in Antimicrobial Susceptibility Testing None. S. Das: None.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) J. B. Patel, None. Discovery to Implementation: What We Need to Get New Drugs and Diagnostics for Antibiotic Resistant Infections J. B. Patel, None. Novel Strategies to Help Antibiotics to Play their Role M. B. Patel, None. G. W. Gokel, None. M. Patel: None. V. Stojanoski: None. C. Adamski: None. B. Fryszczyn: Carbapenemases None. T. Palzkill: None. Antimicrobial Research Award Lecture: Quinolone and Multidrug Resistance - A Formidable Foe R. Patel, None. Literature Review D. Paterson, None. Infectious Disease Quiz D. Paterson, None.

M. Pathiraja: None. E. Mckle: None. N. Damani: None. E. Porter: Nosocomial Outbreaks None. A. McCorry: None. K. Hopkins: None. J. Turton: None. Controversies in Antimicrobial Stewardship M. Paul, None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing M. Paul, None. Escherichia coli : A Friend or an Enemy? G. Peirano, None. Infectious Disease Quiz A. Y. Peleg, None. Microbe 2016 Disclosures Listed by Session

Biosafety and Biosecurity Lessons to Be Learned M. A. Pentella, None. Myths in Infection Control E. N. Perencevich, Merck & Co., Inc. Grant Investigator. Prevention and Treatment of Infection in the lmmunocompromised Child S. A. Pergam, Merck Consultant. Merck, Chimerix, Cubist Research & Adolescent Relationship. Big Challenges in Pre-clinical Med Student Microbiology Education (Supported jointly by IDSA and AMSMIC) E. Peter V. Chin-Hong, None. Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly with the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical W. A. Petri, Perrigo Nutritionals Consultant. TechLab, Inc Consultant. Medicine and Hygiene (ASTMH)) Seres Therapeutics Consultant. C. Petti, Ancestry Employee. Pathogenomix Scientific Advisor (Review AST Update: Clinical and Laboratory Impact Panel or Advisory Committee).

V. Philippe, GSK Scientific board In France, Board Member. BIOMERIEUX Control of Nosocomial Influenza Transmission: What Have We Missed? Consultant. SANOFI PASTEUR, ANIOS Research Relationship. Early New Antimicrobial Agents P. Picconi, None. Pediatric Microbiology for Clinicians and Laboratorians B. Pinsky, None. D. Pires: None. H. Soule: None. F. Bellissimo-Rodrigues: None. A. Hand Hygiene and Environmental Issues in the Healthcare Setting Gayet-Ageron: None. D. Pittet: None. Nosocomial Outbreaks D. Pittet, None.

ICAAC Lecture: Clean Hands Save Lives: Worldwide Perspectives D. Pittet, None.

Genome-wide Association Studies and Comparative Genomics for Tracking Multi-resistant and Hypervirulent Bacterial Clones P. J. Planet, None. Bioinformatic Tools for WGS-based Typing of MDR Bacteria P. J. Planet, None. Models and Technologies for Studying Pathogenesis P. J. Planet, None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? M. Plebani, None. Escherichia coli : A Friend or an Enemy? L. Poirel, None L. Poirel: None. N. Kieffer: None. A. Brink: None. J. Coetze: None. New insights on Emerging Resistance Mechanisms in Gram-negatives P. Nordmann: None.

The Resistance Network: Interplay between Environmental, Community and Nosocomial Superbugs (Joint ASM-FEMS Symposium) L. Poirel, None Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: A Cases Based Discussion L. Poirel, None Hot Topics in Vaccines (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) A. J. Pollard, None. Preventing Pediatric Infection (Supported jointly by the Bill & Melinda Gates Foundation) (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) A. J. Pollard, None. Emerging Viral Infections N. R. Pollock, None. Alexander Fleming and the Beginnings of Biofilm Research J. A. Poupard, None. D. De Belder: None. B. Ghiglione: None. G. Gutkind: None. F. Pasterán: None. M.M. Rodríguez: None. A. Corso: None. S. Gómez: Carbapenemases None. P. Power: None.

A. L. Pozniak, Clinical Trials for BMS, Merck,Gilead and ViiV, Investigator. Advisory board Janssen, BMS, Merck,Gilead and ViiV, Scientific Advisor (Review Panel or Advisory Committee). Gilead Speaker's Bureau. EACS Treatment of HIV Infection and BHIVA Guidelines committeees Antimicrobial Resistance Control: A One-Health Approach L. Price, None. Global Health and Emerging Infections B. S. Pritt, None. More Trouble from Ticks in 2016 B. S. Pritt, None. Microbe 2016 Disclosures Listed by Session

G. Procop, bioMerieux Grant Investigator. Hardy Diagnostics Grant Investigator. Bruker Grant Investigator. Qiagen Grant Investigator. Course in Medical Mycology Hologics Grant Investigator. Antimicrobial Stewardship I C. Pulcini, None. Controversies in Antimicrobial Stewardship C. Pulcini, None. Antimicrobial Resistance Control: A One-Health Approach C. Pulcini, None. Microbiology in the World of Social Media V. Racaniello, None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance M. Rahman: None. S.V. Nguyen: None. K.A. McCullor: None. C.J. King: in Gram-positive Bacteria None. J.H. Jorgensen: None. W.M. Mcshan: None. Fresh Approaches to Antibiotic Drug Discovery: Breaking from L. G. Rahme, Spero Therapeutics Shareholder (excluding diversitied mutual Convention funds).

J.C. Ramos: None. J.R. Arribas: None. F. Arnalich: None. J. Garcia: None. J. Mingorance: None. R. Herruzo: None. G. Ruiz: None. A. Epidemiology and Control of Nosocomial MDRO Borobia: None. F. Lázaro: None. J.R. Paño: None. Myths in Infection Control D. Raoult, None. Discovery to Implementation: What We Need to Get New Drugs and Diagnostics for Antibiotic Resistant Infections A. Ratcliffe, None.

Interactive Cases in Pediatric Infectious Diseases (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) A. Ratner, None. Hot Topics in Antimicrobial Susceptibility Testing C. Rauch, None. Preparing Your Education and Engagement Research for Publication: Qualitative Research for Dummies J. Redfern, None. Forty Years after the Double Bind E. Reuben, None.

Antimicrobial Stewardship II C. Reuter: None. T. Hudson: None. C. Nguyen: None. J. Li: None. Practical Project Management for Scientists R. Ribaudo, None. K. Timm: None. E.M. Richards: None. M. Dodd: one. K. Culbreath: Hot Topics in Antimicrobial Susceptibility Testing None. Primer on Transplantation C. Richardson, None. Integration of MALDI-TOF MS in Clinical Laboratories-Two Laboratories' S. Richter, bioMerieux Research Relationship. BD Diagnostics Research Experiences Relationship.

Control of Nosocomial Influenza Transmission: What Have We Missed? J. Ridgway, None.

S. Riedel, Planet Innovation Consultant. Centers of Disease Control & Prevention (CDC), Goncoccal Isolate Surveillance Program (GISP) Grant Investigator. CAP Microbiology Resource Committee Member. JMI Laboratories, Liberty, IA Research Relationship. OpGen, Inc. ; UK General Guess the Resistance Mechanism (Organized in Cooperation with the Medical Research Council Scientific Advisor (Review Panel or Advisory Society of Infectious Diseases Pharmacists (SIDP)) Committee). Becton, Dickinson & Co. Speaker's Bureau. Epidemiology and Control of Nosocomial MDRO F. Ramos: None. M. Rigatto: None. A. Zavascki: None. Practical Advice for Lab Management: CPT Codes, Compliance, Reimbursement, and LOINC Codes A. Riley, None. L. W. Riley, Silver Lake Research Corp Collaborator. Silver Lake Research Escherichia coli : A Friend or an Enemy? Corp Research Relationship. T. Riley, Merck Investigator. Alere Research Relationship. Merck Scientific Advisor (Review Panel or Advisory Committee). Sanofi Scientific Advisor Control of C. difficile Infection (Review Panel or Advisory Committee). Forty Years after the Double Bind L. Rissler, None. C.R. Ensor: None. B.A. Falcione: None. R. Venkataramanan: None. M. Clinical Mycology Nguyen: None. J. A. Roberts, Infectopharm Board Member. MSD Grant Investigator. Controversies in Antimicrobial Stewardship MSD Speaker's Bureau.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes A. P. Roberts, None. Microbe 2016 Disclosures Listed by Session

Mycobacteriology 2016: Supporting the Care of Patients with Mycobacterial Infections in an Increasingly Molecular Laboratory Environment B. Robinson-Dunn, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections B. Robinson-Dunn, None.

J. Rodríguez-Baño, Roche Consultant. Merck Consultant. Achaogen Consultant. AstraZeneca Consultant. Pfizer Consultant. Basilea Consultant. InfectoPharm Consultant. Innovative Medicines Initiative Research Relationship. Resistance Surveillance and Public Health .

J. Rodríguez-Baño, Roche Consultant. Merck Consultant. Achaogen Consultant. AstraZeneca Consultant. Pfizer Consultant. Basilea Diagnostic and Therapeutic Challenges in MDR and XDR Gram-Negatives: Consultant. InfectoPharm A Cases Based Discussion Consultant. Innovative Medicines Initiative Research Relationship.

E. Recacha: None. J. Machuca: None. P. Diaz de Alba: None. M. Ramos Güelfo: None. F. Docobo Perez: None. J. Rodriguez Beltran: None. J. RNA Modulation and Cellular Signals in Antimicrobial Resistance Blazquez: None. A. Pascual: None. J. Rodriguez-Martinez: None.

Measurement and Modeling of Drugs in Tissues (Organized in K. A. Rodvold, Rempex/Medicine Company Consultant. Rempex/Medicine Cooperation with International Society of Anti-Infective Pharmacology Company; Tetraphase Scientific Advisor (Review Panel or Advisory (ISAP)) Committee). Medicine Company; Merck/Cubist Speaker's Bureau.

Decreased Antibiotic Efficacy in Renal Impairment: Are We Getting the K. A. Rodvold, Rempex/Medicine Company Consultant. Rempex/Medicine Dose Wrong? (Organized in Cooperation with the Society of Infectious Company; Tetraphase Scientific Advisor (Review Panel or Advisory Diseases Pharmacists (SIDP)) Committee). Medicine Company; Merck/Cubist Speaker's Bureau.

Interplay between Antimicrobial Resistance and Bacterial Persistence N. Role, None. Hot Topics in Vaccines (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) N. Role, None. Cases in Clinical Microbiology N. Role, None.

Harmful Effects of Biocide Overuse in Humans and the Environment (Supported Jointly with the Society for Applied Microbiology (SfAM)) N. Role, None.

Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP)) N. Role, None. Resistance Surveillance and Public Health N. Role, None. Emerging Viral Challenges N. Role, None. President's Forum - Viruses: Vital Members of Polymicrobial Communities M. Roossinck, None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance M. Fatouraei: None. M. Martinez Moral: None. M. Roch: None. I. Yun: in Gram-positive Bacteria None. W. Rose: None. A.E. Rosato: None.

Tricky Choices Regarding Appropriate Antimicrobial Prescribing W. Rottier, Merck Sharp & Dohme Grant Investigator. Prevention and Treatment of Infection in the lmmunocompromised Child & Adolescent C. E. Rubens, None.

Microbiology Career Choices: What's Available and How to Succeed L. J. Runyen-Janecky, None. Microbe 2016 Disclosures Listed by Session

NIAID Training (T), Career (K), and Fellowship (F) Opportunities L. Rust, None. Tips for Writing Grant Applications L. Rust, None. C. Sabin, ViiV Healthcare, Janssen-Cilag, Gilead Sciences Scientific Advisor (Review Panel or Advisory Committee). Gilead Sciences Speaker's Bureau. Preparation of educational materials for: ViiV Healthcare, Gilead Sciences, HIV Cohorts Studies Janssen-Cilag

H. S. Sader, JMI Laboratories, Inc. has also received research and educational grants in 2014-2015 from Achaogen, Actavis, Actelion, Allergan, American Proficiency Institute (API), AmpliPhi, Anacor, Astellas, Research Contractor. AstraZeneca, Basilea, Bayer, BD, Cardeas, Cellceutix, CEM-102 Pharmaceuticals, Cempra, Cerexa, Cidara, Cormedix, Cubist, Debiopharm, Dipexium, Dong Wha, Durata, Enteris, Exela Research Contractor. Forest Research Institute, Furiex, Genentech, GSK, Helperby, ICPD, Janssen, Lannett, Longitude, Medpace, Meiji Seika Kasha, Melinta, Merck, Motif, Nabriva, Novartis, Paratek, Pfizer, Pocared, Research Contractor. PTC Therapeutics, Rempex, Roche, Salvat, Scynexis, Seachaid, Shionogi, Tetraphase, The Medicines Co., Theravance, ThermoFisher, VenatoRX, Vertex, Wockhardt, Resistance Surveillance and Public Health Zavante. Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention H. Sahl, None. Biosafety and Biosecurity Lessons to Be Learned R. Salerno, None. Global Health and Emerging Infections R. Salerno, None. Mycobacteriology 2016: Supporting the Care of Patients with Mycobacterial Infections in an Increasingly Molecular Laboratory Environment M. Salfinger, None. Guess the Resistance Mechanism (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) M. Salfinger, None. Decoding Contamination: Addressing Contamination in the Laboratory, the Hospital and the World S. Salipante, None. Predicting the Impact of Antibiotic Stewardship on AMR: Simulations & Modeling M. H. Samore, None.

D. Sampat: None. A. Wanger: None. G. Holzmann-Pazgal: None. J. Hand Hygiene and Environmental Issues in the Healthcare Setting Butler: None. N. Thosani: None. L. Ostrosky-Zeichner: None.

Error Rates in Clinical Microbiology Laboratories: Where Do We stand? L. P. Samuel, None. Cases in Clinical Microbiology M. Sanguinetti, None. Antimicrobial Stewardship II P. Scapellato, None. GBS Diseases: Global Challenges J. Schlom, None.

Technology Enhanced Learning for the Infectious Diseases and Microbiology Educator (Supported jointly by IDSA and AMSMIC) M. G. Schmidt, None. Big Challenges in Pre-clinical Med Student Microbiology Education (Supported jointly by IDSA and AMSMIC) M. G. Schmidt, None. E.K. Schneider: None. M. Azad: None. Q. Zhou: None. J. Wang: None. J. Huang: None. M. Cooper: None. Y. Doi: None. M. Muller: None. Hot Topics in Antimicrobial Susceptibility Testing J. Li: None. T. Velkov: None. D.M. Schora: None. B. Smith: None. A. Robicsek: None. R.B. Thomson: None. L.R. Peterson: Consultant; Consultant with Cepheid and Roche. Research Relationship; Research Grants with BD, Cepheid and Epidemiology and Control of MRSA Roche. G. Schrank: None. J. Gandhi: None. I.E. Stillman: None. M. Clinical Virology McMasters: None. C.S. Tan: None.

Antimicrobial Stewardship in Hospitals J. Schrenzel, Abbott; bioMérieux, Debiopharm Research Contractor. Microbe 2016 Disclosures Listed by Session

Staphylococcus aureus Infection Treatments: New Compounds, New R. Schuch: Employee; ContraFect Corporation. J. Oh: Employee; ContraFect Strategies Corporation. M. Wittekind: Employee; ContraFect Corporation. The Microbes Are Winning: A Workshop on Antibiotic Resistance, Detection, Distribution (PK/PD), and Molecular Epidemiology in Significant Bacterial Pathogens A. N. Schuetz, None.

Antimicrobial Susceptibility Testing - Where Are We Going? (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) A. N. Schuetz, None. Emerging Viral Challenges S. Schultz-Cherry, None.

Technology Enhanced Learning for the Infectious Diseases and Microbiology Educator (Supported jointly by IDSA and AMSMIC) B. S. Schwartz, None. Big Challenges in Pre-clinical Med Student Microbiology Education (Supported jointly by IDSA and AMSMIC) B. S. Schwartz, None.

Novel Vaccines: From Basic Research Through Clinical Development R. Seedarnee: None. M. Baer: None. D. Bucher: None. Next-Generation Sequencing Applied to Clinical Practice and Pathogen Discovery J. Segre, None. Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution in Clinical and Public Health Microbiology J. Segre, None. M. Roche: None. C. Bornet: None. P. Monges: None. A. Stein: None. Antimicrobial Stewardship I S. Gensollen: None. P. Seng: None. J. Sexton: None. B. Tegtmeier: None. J. Ito: Speaker's Bureau; Astellas, Clinical Mycology Merck. S. Dadwal: None. J. Kriengkauykiat: None.

Interactive Cases in Pediatric Infectious Diseases (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) S. S. Shah, None. Forty Years after the Double Bind A. Shaw, None. Discovery to Implementation: What We Need to Get New Drugs and Diagnostics for Antibiotic Resistant Infections R. Shawar, None. K. Shea: None. A. Hobbs: None. T. Jaso: None. J. Bissett: None. E. Antimicrobial Stewardship I Douglass: None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) S. A. Shelburne, None. Fresh Approaches to Antibiotic Drug Discovery: Breaking from Convention B. Shen, None. Antiretrovirals for Prevention and Treatment A. Shibata, None. Emerging Viral Challenges S. Shresta, None. Attacking the MDR Puzzle from the Direction: Non-Antibiotic Approaches to Treating Bacterial Infections H. A. Shuman, Melinta Therapeutics Consultant. N. Siddique: None. M.A. Abbas: None. S. Rafique: None. R. Farooq: Global Health and Emerging Infections None. K. Naeem: None.

Global Health and Emerging Infections T.R. Siddiqui: None. S. Ghazal: None. S. Bibi: None. W. Ahmed: None. HIV Cohorts Studies M. J. Silverberg, None. AST Update: Clinical and Laboratory Impact P. Simner, None.

PK/PD Questions I Was Too Afraid to Ask (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP)) R. Singh, Past employee of AstraZeneca Pharmaceuticals Inc. Models and Technologies for Studying Pathogenesis E. P. Skaar, None.

M. A. Slavin, Merck Grant Investigator. Pfizer Grant Investigator. Astellas Top 10 Papers in Clinical Mycology (Organized in Cooperation with the Grant Investigator. Gilead Sciences Grant Investigator. Merck Scientific Immunocompromised Host Society (ICHS) & European Confederation of Advisor (Review Panel or Advisory Committee). Gilead Sciences cientific Medical Mycology (ECMM)) Advisor (Review Panel or Advisory Committee). Microbe 2016 Disclosures Listed by Session

M. A. Slavin, Merck Grant Investigator. Pfizer Grant Investigator. Astellas Grant Investigator. Gilead Sciences Grant Investigator. Merck Scientific Advisor (Review Panel or Advisory Committee). Gilead Sciences cientific Aspergillosis following Viral Infections Advisor (Review Panel or Advisory Committee). The Science of Learning M. Smith, None.

M.S. Smith: Employee; Viracor-IBT Laboratories. J. Nutt: Employee; Viracor-IBT Laboratories. B. Schindel: Employee; Viracor-IBT Laboratories. Antiretrovirals for Prevention and Treatment M. Altrich: Employee; Viracor-IBT Laboratories. Challenges of Infections in Lung Transplantation L. Snyder, None. Primer on Transplantation M. So, Merck, Pfizer Consultant. Bacterial Communication V. Sperandio, None. K. St. George, ThermoFisher, Collaborator. Douglas Scientific, Collaborator. Zika Virus: An Emerging Threat ThermoFisher, Research Relationship. K. St. George, ThermoFisher, Collaborator. Douglas Scientific, Collaborator. Global Health and Emerging Infections ThermoFisher, Research Relationship. Epidemiology and Control of Nosocomial MDRO A. J. Stewardson, None. Epidemiological Methods to Evaluate the Added Burden of MDRO Infection A. J. Stewardson, None. Myths in Infection Control A. J. Stewardson, None. G. A. Storch, GenMark, Abbott, FebriDx Consultant. BioFire Grant Clinical Applications of Next Generation Sequencing Investigator.

RNA Modulation and Cellular Signals in Antimicrobial Resistance C. Suelter: Investigator; STRECK. N.D. Hanson: Grant Investigator; STRECK. Course in Medical Mycology D. A. Sutton, None. A. Takahashi-Nakazato: None. N. Goto: None. K. Tsuchiya: None. H. Nosocomial Outbreaks Gatanaga: None. S. Oka: None. Basics of Pharmacokinetics and Pharmacodynamics (PK/PD) of Anti- infective Agents (Organized in Cooperation with International Society of V. H. Tam, The Medicines Company Grant Investigator. Tetraphase, Anti-Infective Pharmacology (ISAP)) Theravance Scientific Advisor (Review Panel or Advisory Committee).

Tricky Choices Regarding Appropriate Antimicrobial Prescribing P. Tamma, None. S.H. Tan: None. W.S. Pang: None. Q.Y. Quek: None. K.L. Chan: None. Epidemiology and Control of MRSA L.C. Eng: None. L.S.Y. Ng: None. T.Y. Tan: None. The Science of Learning K. Tanner, None. E. Tartari: None. F. Bellissimo-Rodrigues: None. D. Pires: None. M. De Kraker: None. C. Kilpatrick: None. B. Allegranzi: None. D. Pittet: Hand Hygiene and Environmental Issues in the Healthcare Setting None. A.M. Tatara: None. A.J. Salter: None. P.D. Kontoyiannis: None. E. Watson: None. N.D. Albert: None. G.R. Bennett: None. A.G. Mikos: New Antifungals None. A.M. Tatara: None. A.J. Salter: None. P.D. Kontoyiannis: None. E. Watson: None. N.D. Albert: None. G.R. Bennett: None. A.G. Mikos: Clinical Mycology None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) Y. Taur, None. Biosafety and Biosecurity Lessons to Be Learned J. Taylor, None. J.L. Taylor: None. D. Balawender: None. M. Neudeck: None. L.E. Parrish- Antiretrovirals for Prevention and Treatment Thompson: None. K. Zamborsky: None. Novel Strategies to Help Antibiotics to Play their Role L. M. Teixeira, None.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes L. M. Teixeira, None. Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance in Gram-positive Bacteria L. M. Teixeira, None. Microbe 2016 Disclosures Listed by Session

Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Continuous and Emerging Challenges, Mechanisms and Epidemiology L. M. Teixeira, None. A.K. Thabit: None. M.L. Monogue: None. D.P. Nicolau: A. Board Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Member; Tetraphase Pharmaceuticals, Inc.. Grant Investigator; Tetraphase (PK/PD) Pharmaceuticals, Inc..

Making an Impact: Utilization and Outcomes in the Microbiology Lab E. S. Theel, None. Basics of Pharmacokinetics and Pharmacodynamics (PK/PD) of Anti- infective Agents (Organized in Cooperation with International Society of Anti-Infective Pharmacology (ISAP)) U. Theuretzbacher, None. Models and Technologies for Studying Pathogenesis W. E. Thomas, None. G.K. Thomson: None. J.W. Snyder: None. Y. Doi: None. K.S. Thomson: Carbapenemases Consultant; BD Diagnostics. Pixels, Paints, and Pop Culture: Unique Perspectives on Science Communication J. Thorp, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives E. Thulin: None. M. Knopp: None. D.I. Andersson: None. More Trouble from Ticks in 2016 R. Tokarz, None.

Interactive Cases in Pediatric Infectious Diseases (Organized in Cooperation with the Pediatric Infectious Diseases Society (PIDS)) K. A. Top, None.

H. A. Torres, Gilead Sciences, Merck & Co., Inc., and Vertex Pharmaceuticals Grant Investigator. Gilead Sciences, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Vertex Pharmaceuticals, Novartis, Genentech, Astellas, Pfizer, and Difficult Viral Infections in HSCT Theravance, Inc. Scientific Advisor (Review Panel or Advisory Committee). Protecting the Food Supply: From Humble Beginnings to Next Generation PulseNet A. Tran, None.

T.T. Tran: None. C. Garcia de la Maria: None. N. Mishra: Grant Investigator; Merck. J. Miro: None. M. Rybak: speaker or have supported research from Allergan, Bayer, Cempra, Merck, Sunovian, The Medicine Company and is partially supported by NIAID R01AI12400-01 and R21 AI109266-01. P. Sullam: None. A. Bayer: Research grants from: NIH- NIAID; ContraFect Corp; Theravance Pharmaceuticals. C. Arias: Consultant; Theravance, Cubist, Bayer. Grant Investigator; Theravance. F. Investigator; Forest. Scientific Advisor (Review Panel or Advisory Committee); Cubist, Deciphering New Mechanisms of Antimicrobial Resistance and Tolerance Bayer.Speaker's Bureau; Forest, Theravance, Pfizer, Astra-Zeneca, the in Gram-positive Bacteria Medicines Company, Cubist, Novartis. Protecting the Food Supply: From Humble Beginnings to Next Generation PulseNet E. K. Trees, None. Ethics in Laboratory Medicine I. Trehan, None.

R. Tsivkovski: Employee; The Medicines Company. M. Totrov: Employee; New Beta-lactamase and Carbapenemase Inhibitors Molsoft. O. Lomovskaya: Employee; The Medicines Company. Antimicrobial Stewardship I P.M. Tulkens: None. P. Turnbaugh, Seres Therapeutics Board Member. Pfizer Consultant. DIY Microbiomes and Metabolomes MedImmune Grant Investigator.

T. Ueda: None. Y. Takesue: None. K. Nakjima: None. K. Ichiki: None. A. Doita: None. Y. Wada: None. T. Tsuchida: None. Y. Clinical Mycology Takahashi: None. M. Ishihara: None. T. Kimura: None. S.B. Vakulenko: None. C. Smith: None. Z. Nossoni: None. M. Toth: Carbapenemases None. N. Stewart: None. Microbe 2016 Disclosures Listed by Session

N.Q. Nguyen: None. K.M. Papp-Wallace: Grant Investigator; Wockhardt, Merck, AstraZeneca, Actavis. R.A. Bonomo: Grant Investigator; Wockhardt, Merck, AstraZeneca, Actavis, GSK. F. van den Akker: Grant Investigator; New Beta-lactamase and Carbapenemase Inhibitors Wockhardt.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes W. van Schaik, None. New Insights Into Enterococcal Pathogenesis and Antibiotic Resistance in the Genomic Era D. Van Tyne, None. Zika Virus: An Emerging Threat P. F. C. Vasconcelos, None. Emerging Viral Challenges P. F. C. Vasconcelos, None. Practical Considerations and Novel Applications of MALDI-TOF MS in the Clinical Laboratory S. Vasoo, None. A. Venkatasubramaniam: None. T. Kort: None. N. Williston: None. S. Patel: None. G. Liao: None. R. Campos: None. R. Adhikari: None. S. Novel Vaccines: From Basic Research Through Clinical Development Krishnan: None. J. Aman: None.

Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) A. Venkatesan, Medimmune, Inc. Board Member. Preparing Your Education and Engagement Research for Publication: Qualitative Research for Dummies J. Verran, None.

Antimicrobial Resistance among Gram-Positive Bacterial Pathogens: Continuous and Emerging Challenges, Mechanisms and Epidemiology B. Vester, None. Parasitology and Anti-parasitic Agents F. Vicente: None. F. Annang: None. President's Forum - Viruses: Vital Members of Polymicrobial Communities H. Virgin IV, PierianDx Founder.

Staphylococcus aureus Infection Treatments: New Compounds, New M. Barbier: None. A. Menetrey: None. A. Haouala: None. J. Bravo: Strategies None. F. Wittke: None. C. Jacqueline: None. G. Vuagniaux: None. F. Wagenlehner, MSD, Bionorica, AstraZeneca, Marpinion, Janssen, Astellas, GSK, Achaogen Consultant. MSD, Bionorica, AstraZeneca, Astellas, New insights into Urinary Tract Infections Achaogen Investigator. Aspergillosis following Viral Infections A. Waghmare, Gilead; Ansun Research Contractor.

J. Wain, Discuva Ltd. Board Member. Bactevo Ltd Board Member. Hoffman La-Roche Collaborator. Hereaus Ltd., Collaborator. Hoffman La- Advances in Clinical Microbiology from the Horse's Mouth Roche Scientific Advisor (Review Panel or Advisory Committee). Nosocomial Outbreaks M. S. Walters, None. K. Wang: None. W. Chou: None. C. Chang: None. W. Chang: None. S. New insights on Emerging Resistance Mechanisms in Gram-negatives Fang: None. AST Update: Clinical and Laboratory Impact H. Wang, None. Early New Antimicrobial Agents P. Warn, Spero Therapeutics Research Contractor.

Prevention and Treatment of Infection in the lmmunocompromised Child A. Warris, Pfizer, Gilead Consultant. Gilead Research Relationship. Basilea & Adolescent Scientific Advisor (Review Panel or Advisory Committee).

Technology Enhanced Learning for the Infectious Diseases and R. Watkins, Certum Informatics, Atlanta GA Board Member. Certum Microbiology Educator (Supported jointly by IDSA and AMSMIC) Informatics, Atlanta GA, Shareholder (excluding diversitied mutual funds). Update on Chikungunya Epidemiology, Treatment and Vaccination (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) S. Weaver, None. Emerging Viral Challenges S. Weaver, None.

Crossing the Diagnostic Divide: The Ongoing Evolution of the Revolution D. Weibel, Agri Diagnostics Inc. Board Member. BluDiagnostics Inc. in Clinical and Public Health Microbiology Board Member. Amazon.com, Inc. Consultant. Novel Insights Regarding the Microbiome and Pregnancy (Organized in Cooperation with the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG)) J. Weitkamp, None. Microbe 2016 Disclosures Listed by Session

Next-Generation Antimicrobial Discovery, Development, and Susceptibility Testing L. Westblade, None. Guess the Resistance Mechanism (Organized in Cooperation with the Society of Infectious Diseases Pharmacists (SIDP)) T. C. White, None. Bacterial Communication M. Whiteley, None. Models and Technologies for Studying Pathogenesis M. Whiteley, None. Developing the Next Gen Scientist: The Role of Course Based Research in the Undergraduate Curriculum C. A. White-Ziegler, None.

Technology Enhanced Learning for the Infectious Diseases and Microbiology Educator (Supported jointly by IDSA and AMSMIC) W. Wiechmann, None.

M. Wilcox, Actelion, Alere, Astellas, AstraZeneca, Basilea, Bayer, Cubist, Durata, European Tissue Symposium, J&J, Merck, Nabriva, Novacta, Optimer, Pfizer, Sanofi Pasteur, Seres Consultant. Abbott, Actelion, Alere, Astellas, Biomerieux, Cerexa, Cubist, Da Volterra, European Tissue Symposium, Merck, Infectious Diseases Treatment Guidelines and Beyond: Where Do We Sanofi Pasteur, Summit, The Medicine Co, Qiagen Research Relationship. Stand in 2016? Pfizer Speaker's Bureau. Control of C. difficile Infection S. Wiles, None. At the Intersection of Art and Microbiology S. Wiles, None. Biosafety and Biosecurity Lessons to Be Learned D. E. Wilson, None.

Encephalitis: What Is New? (Supported Jointly with the Société de Pathologie Infectieuse de Langue Française (SPILF)) M. Wilson, None. Broadly Neutralizing Antibodies I. A. Wilson, None.

C. R. Wolfe, Theravance Consultant. Astellas Consultant. Merck Grant Investigator. Ansun Biopharma Investigator. Gilead Research Contractor. GSK Scientific Advisor (Review Panel or Advisory Committee). Cellerant Therapuetics Scientific Advisor (Review Panel or Advisory Committee). Janssen Pharmaceuticals Scientific Advisor (Review Panel or Advisory Primer on Transplantation Committee).

Clinical Applications of Next Generation Sequencing A. Wolfe, Astellas Scientific and Medical Affairs , Grant Investigator.

New insights into Urinary Tract Infections A. Wolfe, Astellas Scientific and Medical Affairs , Grant Investigator.

The Human Microbiome as a Reservoir of Antimicrobial Resistance Genes P. F. G. Wolffs, None.

New insights on Emerging Resistance Mechanisms in Gram-negatives D. Wolloscheck: None. J. Nguyen: None. H.I. Zgurskaya: None. Protecting the Food Supply: From Humble Beginnings to Next Generation PulseNet A. Woron, None.

G. Wright, Achaogen Research Contractor. Symbal Therapeutics Scientific Advisor (Review Panel or Advisory Committee). Tetraphase Shareholder Bacterial Communication (excluding diversitied mutual funds). Future Microbiology-Predicting the Field in 2026 S. Yang, None. We Are Not Alone: Emerging Issues of the Human Mycobiome (Organized in Cooperation with the lmmunocompromised Host Society (ICHS)) V. B. Young, Merck, Vedanta Consultant. MedImmune Grant Investigator. Environmental Enteropathy During Infancy: Malnutrition and Growth Stunting (Supported jointly with the Bill & Melinda Gates Foundation) (Organized in Cooperation with the American Society of Tropical Medicine and Hygiene (ASTMH)) A. Zaidi, None. S. Zainal: None. L. Phee: None. H. Abdul Momin: None. D. Wareham: New insights on Emerging Resistance Mechanisms in Gram-negatives None. Prevention and Treatment of Infection in the lmmunocompromised Child & Adolescent T. Zaoutis, None. Microbe 2016 Disclosures Listed by Session

E. Zasowski: None. T. Trinh: None. K. Claeys: None. M. Rybak: Consultant; Allergan, Bayer, Cempra, Merck, Sunovian, The Medicines Company, Theravance. Grant Investigator; Allergan, Bayer, Cempra, Merck, Sunovian, The Medicines Company, Theravance, NIAID.Speaker's Bureau; Allergan, Bayer, Cempra, Merck, Sunovian, The Medicines Company, Epidemiology and Control of MRSA Theravance. A. Casapao: Speaker's Bureau; Theravance. D. Zaytseva-Zotova: None. A. Zinchenko: None. T. Levada: None. D. Innovations and Challenges in Pharmacokinetics/Pharmacodynamics Andreev: None. Y. Shilov: None. E. Safarova: None. A. Horhota: None. (PK/PD) G. Troiano: None. S. Zale: None. Measurement and Modeling of Drugs in Tissues (Organized in Cooperation with International Society of Anti-Infective Pharmacology (ISAP)) M. Zeitlinger, None.

NIAID Training (T), Career (K), and Fellowship (F) Opportunities A. Zeituni, None.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology A. M. Zelazny, None.

Update on the Laboratory Diagnosis of Urinary Tract Infections T. Zembower, None. Course in Medical Mycology S. Zhang, IBIS/Abbott Molecular Research Contractor.

Chemistry and Microbiology BFF: Beyond MALDI-TOF MS Technology Z. Zhao, None. Antimicrobial Stewardship I Z. Zhiyong: None. J. Li: None.

RNA Modulation and Cellular Signals in Antimicrobial Resistance X. Zhou: None. Implementation of the Best Infection Control Practices: Worldwide Progress Reports W. Zingg, None.